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1. INTRODUCTION
Graphene is composed of single-atom thick sheets of sp2 bonded carbon atoms that are 
arranged in a perfect two-dimensional (2D) honeycomb lattice. Because of this structure, 
graphene is characterized by a number of unique and exceptional structural, optical, and 
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electronic properties.1 Specifically, these extraordinary properties include, but are not 
limited to, a high planar surface area that is calculated to be 2630 m2 g−1,2 superior 
mechanical strength with a Young’s modulus of 1100 GPa,3 unparalleled thermal 
conductivity (5000 W m−1 K−1),4 remarkable electronic properties (e.g., high carrier 
mobility [10 000 cm2 V−1 s−1] and capacity),5 and alluring optical characteristics (e.g., high 
opacity [~97.7%] and the ability to quench fluorescence).6 As such, it should come as no 
surprise that graphene is currently, without any doubt, the most intensively studied material 
for a wide range of applications that include electronic, energy, and sensing outlets.1c 
Moreover, because of these unique chemical and physical properties, graphene and 
graphene-based nanomaterials have attracted increasing interest, and, arguably, hold the 
greatest promise for implementation into a wide array of bioapplications.7
In the last several years, numerous studies have utilized graphene in bioapplications ranging 
from the delivery of chemotherapeutics for the treatment of cancer8 to biosensing 
applications for a host of medical conditions9 and even for the differentiation and imaging of 
stem cells.10 While promising and exciting, recent reports have demonstrated that the 
combination of graphene with nanomaterials such as nanoparticles, thereby forming 
graphene–nanoparticle hybrid structures, offers a number of additional unique 
physicochemical properties and functions that are both highly desirable and markedly 
advantageous for bioapplications when compared to the use of either material alone (Figure 
1).11 These graphene–nanoparticle hybrid structures are especially alluring because not only 
do they display the individual properties of the nanoparticles, which can already possess 
beneficial optical, electronic, magnetic, and structural properties that are unavailable in bulk 
materials, and of graphene, but they also exhibit additional advantageous and often 
synergistic properties that greatly augment their potential for bioapplications.
In general, these graphene–nanoparticle hybrid materials can be categorized into two classes 
(Figure 2). They can exist as (1) graphene–nanoparticle composites, where the nanoparticles 
decorate or are grown on graphene sheets (Figure 2A and B), or (2) graphene-encapsulated 
nanoparticles wherein the nanoparticle surface is wrapped or coated with graphene (Figure 
2C and D). In particular, graphene–nanoparticle hybrid structures can be synthesized by 
combining graphene or its derivatives, graphene oxide (GO) and reduced graphene oxide 
(rGO), with various types of nanoparticles including, but not limited to, quantum dots 
(QDs), metal (e.g., noble metal and magnetic), metal oxide, or silica nanoparticles (SiNPs), 
depending on the final functional properties that are desired. By combining these unique and 
robust materials, a striking synergy can often be achieved. For instance, the decoration of 
metal or metal oxide nanoparticles on graphene surfaces has been shown to have 
implications on the charge transfer behavior in graphene through the modification of the 
local electronic structure.12 As a result, this type of composite material can show improved 
performance as catalysts. On the other hand, in sensing applications, the combination of 
nanoparticles, which have excellent conductivity and catalytic properties, with graphene 
materials allows for the enhancement of achievable sensitivity and selectivity over either 
graphene or nanoparticle-based sensors alone.11a,13 Finally, by combining graphene with 
nanoparticles, it is possible to deliver cargo (e.g., small molecule drugs, nucleic acids, etc.) 
to target cells (e.g., cancer cells or stem cells) while enabling complementary 
multifunctionalities such as imaging (e.g., surface-enhanced Raman spectroscopy [SERS] or 
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magnetic resonance imaging [MRI]) and hyperthermia (e.g., using near-infrared [NIR] 
radiation).14
In this Review, we will systematically discuss graphene–nanoparticle hybrid materials in 
terms of their synthesis, characterization, and implementation to a host of bioapplications. 
While there are already numerous excellent reviews that cover graphene synthesis, its 
chemical and physical properties, and its bioapplications,1,15 graphene–nanoparticle hybrid 
materials and their implementation into bioapplications is a relatively new area that has not 
been comprehensively reviewed. Moreover, graphene–nanoparticle hybrid materials are 
gaining significant traction in the field of graphene research, where, in 2013, approximately 
20% of all papers published on graphene involved the synthesis and application of 
graphene–nanoparticle hybrid materials (Figure 3). Thus, we present the first complex work 
covering all modes and methods for the synthesis of graphene–nanoparticle hybrid materials, 
its unique chemical and physical properties, and, most importantly, its utilization for 
bioapplications. Specifically, we will focus on graphene–nanoparticle hybrid materials for 
biosensing, multifunctional drug delivery, imaging, as well as for the control of stem cell 
differentiation with particular emphasis on the advantages and differences that are conferred 
by the use of graphene–nanoparticle hybrid materials over conventional methods in each 
area. We will also discuss trends, future directions, and any controversies that exist in the 
field. As a result, we hope that this Review will inspire interest from various disciplines and 
highlight an up and coming field wherein graphene–nanoparticle hybrid structures can bring 
significant advantages to a wide variety of bioapplications.
2. SYNTHESIS AND CHARACTERIZATION OF GRAPHENE–NANOPARTICLE 
HYBRID MATERIALS
Because of the many unique and advantageous properties of graphene and its derivatives, 
GO and rGO, a significant amount of effort has been invested in utilizing these materials 
either by themselves, or in combination with other interesting nanomaterials such as 
nanoparticles. As mentioned previously, graphene–nanoparticle hybrid materials can be 
broadly categorized into two main classes on the basis of their structural morphology. They 
can exist as (1) graphene–nanoparticle composites, where nanoparticles are decorated or 
grown on sheets of graphene or its derivatives, and (2) graphene-encapsulated nanoparticles 
wherein nanoparticles are wrapped by graphene or its derivatives. The main difference 
between these two classes can be found in the relative size ratio that exists between the 
diameter of the nanoparticles and the lateral dimensions of the graphene sheets. Specifically, 
when the diameter of the nanoparticles is in the range of a few nanometers to about a 
hundred nanometers, the nanoparticles are generally small in comparison to the graphene 
sheets and can easily be decorated onto the sheets, thereby forming graphene–nanoparticle 
composites. On the other hand, when the size of the nanoparticles is larger and becomes 
more comparable with the graphene sheets, the small 2D sheets can be wrapped around the 
nanoparticles resulting in graphene-encapsulated nanoparticles. In this section, we will begin 
by briefly describing the primary methods used to produce graphene, GO, and rGO. This 
will be followed by an in-depth analysis of the various methods that have been developed for 
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the synthesis of graphene–nanoparticle hybrid structures, with particular emphasis on the 
properties and characteristics that result from these different procedures.
2.1. Graphene and Graphene Oxide
Graphene sheets can be obtained using a number of procedures; however, there are three 
primary methods, which include: (1) mechanical exfoliation, (2) chemical vapor deposition 
(CVD) onto metal or Si substrates, and (3) the chemical, electrochemical, or thermal 
reduction of GO (Figure 4). For the mass-production of graphene, the CVD method is the 
most effective and can be used to fabricate large areas of graphene while limiting the 
number of defects.16 Consequently, graphene that is obtained using the CVD method can 
have a carrier mobility that reaches values as high as ~2000–4000 cm2 V−1 s−1.17 On the 
other hand, mechanical exfoliation using the Scotch tape method or by rubbing 
lithographically patterned pillars with “tipless” atomic force microscopy (AFM) cantilevers 
can be used to generate very high-quality graphene with a carrier mobility that reaches ~10 
000 cm2 V−1 s−1 at room temperature.18 Using this method, the physical limit of the 
graphene sheets that are produced has lateral dimensions on the order of tens to hundreds of 
micrometers. However, mechanical exfoliation has poor reproducibility and is not amenable 
to large-scale fabrication.1c Finally, the reduction of GO has also been demonstrated to be a 
relatively economical and facile technique for the production of graphene and will be 
explained in more detail below; however, it has been reported that the quality of these 
graphene (rGO) sheets, in terms of electrical conductivity, is generally lower than that 
produced using the other two methods described.19 As such, overall, the reduction method is 
a better fit for the mass-production of small graphene sheets, while the CVD method is more 
efficient for the mass-production of high-quality graphene. Hence, the application for which 
graphene is being synthesized must first be considered before the appropriate synthesis 
method can be selected (Figure 4).
On the other hand, GO has many distinct characteristics that greatly differentiate it from 
those of graphene due to the presence of numerous oxygen-containing hydroxyl and epoxy 
groups on the basal plane, along with smaller quantities of carboxyl, carbonyl, phenol, 
lactone, and quinone that are present at the edges,20 which collectively act to inhibit electron 
transfer (Figure 5A and B). Specifically, GO films are hydrophilic and typically insulating 
with an energy gap in the electron density of states and a sheet resistance of about 1012 Ω sq
−1
 or higher.21 However, similar to graphene, GO exhibits excellent electronic, thermal, 
electrochemical, and mechanical properties and is flexible, transparent, and also 
biocompatible due to its hydrophilic nature. In terms of its fabrication, GO is most 
commonly produced using the Brodie, Staudenmaier, and Hummer methods or some 
variation of these methods.19b,22 All three methods involve the oxidation of graphite to 
various levels resulting in the formation of hydrophilic groups on the surface. In particular, a 
combination of potassium chlorate (KClO3) and nitric acid (HNO3) is typically used to 
oxidize graphite in the Brodie and Staudenmaier methods, while potassium permanganate 
(KMnO4) and sulfuric acid (H2SO4) are used in the Hummer method.23 After the oxidation 
process, the resulting product is then exfoliated to obtain one- or multilayered GO sheets 
with ultrasonication being the most commonly used procedure.
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Finally, as mentioned above, rGO can be obtained from GO through chemical, 
electrochemical, or thermal reduction, which removes the oxygen-containing branches from 
the basal planes and edges of the GO sheets (Figure 5C).22,24 As a consequence, the 
electrical conductivity of GO (as well as its thermal stability) can be restored close to the 
levels found in graphite. Specifically, the electrical conductivity of rGO has been reported to 
fall within the range of 200–42 000 Sm−1.19a,25 However, this depends significantly on the 
parameters used during reduction, including the type of reducing agent, duration of 
reduction, temperature, annealing time, and annealing temperature. Moreover, while the 
specific capacitance of rGO is significantly higher than that of GO, the transparency and 
dispersibility of rGO are significantly reduced when compared to pure GO sheets. To form 
rGO from GO, hydrazine, hydroquinone, ascorbic acid (AA), and sodium borohydride are 
commonly used to remove the hydroxyl groups from GO. Electrochemical tools can also be 
used to fabricate rGO. For instance, this can be accomplished using either acidic (e.g., 
sulfuric acid) or nonacidic solutions such as Na-phosphate-buffered saline (PBS), K-PBS, 
NaOH, and KCl in the presence of a constant reduction potential or sweeping potential.26 
Finally, thermal reduction is also a well-known method for the removal of oxygen functional 
groups from the surface of GO. In this method, oxygen functional groups are removed in the 
form of water, carbon dioxide, and carbon monoxide by placing the GO sample in a 
preheated furnace at 1000–1100 °C for 30–45 s in the absence of air.27 However, chemical 
and electrochemical methods tend to be preferred as they can be performed under more mild 
conditions.
2.2. Graphene–Nanoparticle Composites
Graphene–nanoparticle composites, wherein sheets of graphene, GO, or rGO, are decorated 
with nanoparticles that are a few nanometers to a couple hundred nanometers in diameter,28 
can be obtained by anchoring various types of nanoparticles to the surface of graphene 
sheets through both in situ (e.g., growing the nanoparticles on the graphene surface) and ex 
situ (e.g., attaching premade nanoparticles to the graphene surface) methods. GO and rGO 
are especially promising templates for this purpose as the presence of defects and oxygen 
functional groups on their surfaces allows for the nucleation, growth, and attachment of 
various metal (e.g., Au,29 Ag,30 Pt,31 etc.) and metal oxide nanoparticles (e.g., Fe3O4,32 
TiO2, 33 ZnO,34 SnO2,35 Cu2O,36 MnO2,37 NiO,38 etc.). The resulting graphene–
nanoparticle composites are then able to offer numerous unique and advantageous properties 
for various applications depending on the particular characteristics possessed by the 
nanoparticles used to form the composites. For example, graphene–nanoparticle composites 
can confer excellent catalytic activity, enhancements in mass transport, and a significantly 
higher effective surface area.20b As such, recent efforts in this area have not only focused on 
methods to form graphene–nanoparticle composites while preserving the excellent 
properties of graphene but also on precisely tuning the physicochemical features that are 
present. In this section, we will give a comprehensive review of the different methods that 
are available for the preparation of graphene–nanoparticle composites including various in 
situ (e.g., reduction, hydrothermal, and electrochemical) and ex situ methods (Table 1). We 
will specifically focus on the distinct characteristics and properties that each technique 
imparts on the resulting graphene–nanoparticle composite.
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2.2.1. Reduction Methods To Form Graphene–Nanoparticle Composites—
Graphene–metal nanoparticle composites are most frequently fabricated via the reduction of 
metallic salts (e.g., HAuCl4, AgNO3, and K2PtCl4) using chemical agents such as ethylene 
glycol, sodium citrate, and sodium borohydride.30,39 More specifically, the negatively 
charged functional groups that exist on the surface of GO allow for the nucleation of 
positively charged metallic salts, resulting in the growth of metal nanoparticles on the GO 
surface. By utilizing this method to form rGO–metal nanoparticle composites, it is possible 
to preserve the excellent electrical properties of graphene. Moreover, by controlling the 
density of oxygen-containing groups on the GO and rGO surface, one can easily tune the 
density of nanoparticles formed on the resulting graphene–nanoparticle composites. In 
general, to form graphene–metallic nanoparticle composites in situ via reduction, a one-step 
method is used wherein the metal precursor and GO sheets are mixed in an aqueous solution 
and then reduced simultaneously (Figure 6). This reaction is similar to conventional 
nanoparticle synthesis methods and follows three steps: (1) reduction, (2) nucleation, and (3) 
nanoparticle growth. More specifically, the functionalities that exist on the GO and rGO 
surface, such as alcohols, carbonyl groups, and acids, are responsible for the attachment of 
free metal ions through electrostatic interactions. Subsequently, the addition of a reducing 
agent promotes the reduction of the attached metal ions, thereby enabling the growth of 
metal nanoparticles on the GO and rGO surfaces.40 While this method is highly efficient and 
easy to perform, the size and morphology of the metal nanoparticles on the resulting 
composite can be difficult to control, resulting in samples that are decorated with 
nanoparticles that have a wide size distribution.41
To date, the reduction technique has been used primarily for the preparation of graphene–
noble metal nanoparticle composites. Noble metal nanoparticles, especially gold (AuNP) 
and silver nanoparticles (AgNPs), are among the most extensively studied nanomaterials and 
have led to the development of numerous biotechniques and applications including 
diagnostics, imaging, drug delivery, and other therapeutics.42 Noble metal nanoparticles are 
of particular interest because of their unique and unusual properties such as high 
biocompatibility and optical properties (e.g., surface plasmon resonance), which can easily 
be tuned to the desired wavelength according to their shape (nanoparticles, nanoshells, 
nanorods, etc.), size, and composition.43 In addition, when combined with graphene as a 
composite, graphene–noble metal nanoparticle hybrids are able to exhibit SERS as well as 
enhanced catalytic potential.44 To this end, numerous methods have been used to fabricate 
graphene–AuNP composites, which are currently the most commonly prepared and utilized 
graphene–nanoparticle composite. Briefly, graphene–AuNP composites can be attained by 
mixing HAuCl4 precursor with exfoliated GO and sodium citrate, resulting in gold 
precursors anchoring to the surface of GO via electrostatic interaction. Afterward, the gold 
precursors are reduced using NaBH4 to form AuNPs.45 Similarly, graphene–AgNP 
composites can be obtained by mixing GO with AgNO3, followed by reduction with 
NaBH4.46 Finally, graphene decorated with platinum or palladium nanoparticles has also 
been produced by mixing graphene with chloroplatinic acid (H2PtCl6) or tetrachloropalladic 
acid (H2PdCl4), followed by reduction with ethylene glycol, respectively.47 In terms of the 
characteristics that are imparted by the formation of graphene–noble metal nanoparticle 
composites, Subrahmanyam et al. recently studied the interaction between noble metal 
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nanoparticles and graphene utilizing Raman spectroscopy.47a Specifically, they reported that 
the decoration of graphene with noble metal nanoparticles results in electronic interactions 
that give rise to significant changes in the ionization energies of the metals as well as in their 
charge-transfer interaction and, subsequently, the Raman spectrum of the graphene sheets.
On the other hand, graphene–nanoparticle composites containing bimetallic nanoparticle 
hybrids can also be obtained utilizing a two-step reduction process. By fabricating such a 
structure, not only can synergism be achieved between the different nanoparticle species that 
are present but also between the bimetallic nanoparticles and graphene.48 For example, the 
reduction of H2PdCl4 by formic acid, followed by the addition of K2PtCl4 and reduction by 
AA, yielded a graphene–PtPd bimetallic nanoparticle composite structure (Figure 7).49 The 
resulting bimetallic hybrid composite showed much higher catalytic activity than 
conventional graphene–platinum nanoparticle (PtNP) hybrid structures and PtPd bimetallic 
catalysts. This can be attributed to a combination of the increased surface area of Pt in 
bimetallic nanoparticles, which is an essential factor in improving catalytic activity, as well 
as their better dispersion on graphene nanosheets that have a high surface area.50 Similarly, 
Yang et al. described the preparation of another bimetallic nanoparticle hybrid wherein GO 
was decorated with PtCo bimetallic nanoparticles.48b In this case, ethylene glycol-
functionalized GO sheets were loaded with PtCo bimetallic nanoparticles by the addition of 
H2PtCl6 and CoCl2 at room temperature, followed by reduction with NaBH4. Similar to the 
graphene–PtPd bimetallic nanoparticle composites, the resulting graphene–PtCo bimetallic 
nanoparticle composite also exhibited good stability, resistance to degeneration, and an 
especially high catalytic activity as compared to other PtNPs and graphene–PtNP 
composites, presumably for the same reasons as mentioned for graphene PtPd composites.
Finally, as an alternative to the traditional reduction methods used to prepare graphene–
nanoparticle composites, microwaves can also be used as a source of energy that facilitates 
the process.51 For instance, graphene and its derivatives were decorated with metal (e.g., Au,
51
 Ag,52 and Pt53) and metal oxide (e.g., Co3O4 and MnO2) nanoparticles,54 in the presence 
or absence of reducing agents and stabilizing molecules, with the help of rapid microwave 
irradiation. The main advantage of microwave irradiation is the uniform and rapid heating of 
the reaction mixture, thereby reducing the barrier to reduction, nucleation, and ion 
incorporation.55 Hence, nanoparticles with a very small size and narrow size distribution can 
be obtained.
2.2.2. Hydrothermal Methods To Form Graphene–Nanoparticle Composites—
The hydrothermal method is also commonly used to synthesize inorganic nanoparticles that 
have a high crystallinity and narrow size distribution on graphene sheets. Moreover, this 
method allows for the formation of nanoparticles on graphene without the need for 
postannealing and calcination.11b In general, the process involves the use of high 
temperatures and pressures, which induce the growth of nanocrystals and, at the same time, 
reduce GO to rGO. However, while the high temperature and long reaction times can 
partially or completely reduce GO on its own, in most cases, reducing agents are added to 
ensure the complete reduction of GO.11b,56
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Graphene–metal oxide nanoparticle composites (e.g., ZnO,57 TiO2,58 Fe3O4,59 SnO2,60) are, 
by far, the most common hybrids synthesized using the hydrothermal method. Specifically, 
metal oxide nanoparticles can provide the graphene–metal oxide nanoparticle hybrids with a 
number of advantages such as a higher capacitance, which depends on the nanoparticle 
structure, size, and crystallinity, while suppressing agglomeration and the restacking of 
graphene.61 Moreover, graphene–metal oxide nanoparticle composites result in enhanced 
electron conductivity, shortened ion paths, and a significant increase in the available surface 
area when compared to graphene alone, which altogether lead to higher electrochemical 
activity.11c For example, in 2012, Park et al. reported the one-pot synthesis of rGO–SnO2 
nanoparticle composites, wherein the resulting composites exhibited outstanding cycling 
performance and could be used as an electrode.60b In their study, a hydrothermal synthesis 
assisted by hydrazine, which promoted the complete reduction of GO to rGO, was utilized. 
The resulting composites exhibited a first discharge capacity of 1662 mA h g−1, which 
rapidly stabilized and remained at 626 mA h g−1 even after 50 cycles when cycled at a 
current density of 100 mA g−1, whereas the capacity of pure SnO2 nanoparticles decreases 
continuously. This could be attributed to the lack of aggregation in the rGO-supported SnO2 
composites and the uncontrolled aggregation of the pure SnO2 nanoparticles. On the other 
hand, Ren et al. reported the synthesis of graphene–magnetic nanoparticle (MNP) 
composites. In particular, these graphene–MNP composites exhibited excellent electrical 
conductivity and mechanical strength while possessing the magnetic properties of the 
attached MNPs.62 In this case, a one-step hydrothermal method was performed, wherein 
anhydrous FeCl3 provided the source of iron, and ethylene glycol (or a bisolvent of 
diethylene glycol and ethylene glycol) was used as the reductant and solvent. Consequently, 
Fe3O4 nanoparticles with a diameter of 7 nm were densely and uniformly deposited on the 
rGO sheets. Moreover, the reduction of GO by this process was comparable to that achieved 
by conventional methods. For example, the D/G intensity ratio of rGO in the aforementioned 
hybrids was 2.30:1, which is similar to the ratio typically obtained for pristine graphene 
(2.45:1), indicating the recovery of the sp2 domain in the carbon network.62
In addition, various chalcogenide QDs such as CdS,63 ZnS,64 Cu2S,65 MoS2,66 Sn3S4,67 and 
CdTe68 have been successfully immobilized on graphene utilizing hydrothermal methods. 
These semiconductor nanostructures have attracted intense interest due to their fundamental 
importance as well as their enormous potential in optoelectronic, magnetic, and catalytic 
applications.69 Specifically, for biological applications, QDs provide a high quantum yield 
(0.1–0.8 [visible], 0.2–0.7 [NIR] vs 0.5–1.0 [visible], 0.05–0.25 [NIR] for organic dyes),70 
high molecular extinction coefficients (~10–100× that of organic dyes),71 broad absorption 
with narrow symmetric photoluminescence spectra (full-width at half-maximum ~25–40 
nm) spanning from ultraviolet (UV) to NIR, high resistance to photobleaching, and 
exceptional resistance to photo- and chemical degradation.72 Moreover, because of their 
size-tunable fluorescence emission and the broad excitation spectra, QDs have a significant 
advantage over molecular dyes. However, these semiconductor nanoparticles are limited by 
their tendency to aggregate, resulting in a reduction in the surface area that is available for 
subsequent applications. In terms of the fabrication of rGO–sulfide nanocomposites, the 
sulfur sources often act as a reducing agent for GO. Zhang et al. recently reported the 
synthesis of graphene–CdS nanoparticle composites wherein a facile one-step hydrothermal 
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approach was utilized to simultaneously form CdS nanoparticles and reduce GO (Figure 8).
73
 By combining these two excellent materials in a single composite, the graphene–CdS 
nanoparticle composites were able to serve as promising visible-light-driven photocatalysts, 
whose excellent photoactivity could be attributed to the integrative effect of the enhanced 
light absorption intensity, high electron conductivity of graphene, which significantly 
prolonged the lifetime of photogenerated electron–hole pairs, and its significant influence on 
the morphology and structure of the samples (e.g., the density and size of the nanoparticles 
could be controlled during synthesis).
Finally, there have also been some reports utilizing hydrothermal methods for the 
preparation of rGO–noble metal nanoparticle composites (Figure 9).74 In the case of 
graphene–AuNPs, a solution of HAuCl4·3H2O and NaOH was mixed with GO.75 
Subsequently, the solution was sonicated at a frequency of 40 kHz and heated to 180 °C. The 
resulting graphene–AuNP composites had AuNPs with a narrow size distribution in the 
range of 2 or 18 nm, with and without sonication, respectively. Graphene–Pt or –Pd 
nanoparticle composites can also be prepared by a similar method using H2PtCl6·6H2O and 
PdCl2, respectively.75 Moreover, graphene–bimetallic nanoparticle hybrid composites have 
been reported using the hydrothermal method. For instance, platinum–ruthenium 
nanoparticles with a mean size of 2.17 nm were decorated on graphene nanosheets, and it 
was found that the size and morphology of these nanoparticles could easily be controlled by 
modifying the synthesis temperature and the initial materials used.76
2.2.3. Electrochemical Methods To Form Graphene–Nanoparticle Composites
—Electrochemical deposition is a simple, fast, and green technique that can be used to form 
graphene–nanoparticle composites while preventing the contamination of the synthesized 
materials. In addition, it is low cost, easy to miniaturize and automate, and is highly stable 
and reproducible.77 As such, by utilizing electrochemical deposition, the size and shape of 
the nanoparticles that are deposited can be precisely controlled by simply altering the 
conditions of electrochemical deposition. In particular, electrochemical deposition methods 
have been developed extensively for the fabrication of graphene–inorganic nanoparticle 
composites with the vast majority of composites formed using this method being noble 
metals such as Au,78 Ag,79 Pt,80 as well as bimetallic metals.
In a typical electrochemical deposition experiment, there are three steps wherein (1) the 
graphene sheets are first assembled onto an electrode, (2) the graphene-coated electrode is 
then immersed in an electrolytic solution containing metallic precursors, and (3) a potential 
is applied. For the formation of graphene–AgNP composites, Golsheikh and co-workers 
recently reported an electrochemical deposition method wherein the resulting nanoparticles 
fell within a very narrow size distribution with a mean size of 20 nm.79 In this case, a 
solution containing silver–ammonia [Ag(NH3)2OH] and GO was exposed to cyclic 
voltammetry (CV), which was performed using a three-electrode system that consisted of an 
indium tin oxide (ITO) working electrode, a platinum foil counter electrode, and a saturated 
calomel electrode (SCE) reference electrode (scanning between −1.5 and 0 V at a rate of 25 
mV s−1). Fisher et al. also utilized electrochemical tools to fabricate graphene–PtNP 
composites wherein PtNPs were decorated on multilayered graphene petal nanosheets 
(MGPNs).80b According to their report, a three-electrode system, wherein the MGPNs acted 
Yin et al. Page 9
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
as the working electrode, Pt gauze as the auxiliary electrode, and Ag/AgCl as the reference 
electrode, was dipped in a solution containing H2PtCl6·6H2O and Na2SO4. Utilizing this 
method, the density, size, and morphology of the PtNPs could be precisely controlled by 
simply adjusting the intensity of the pulse current. In particular, this allowed for the 
simultaneous reduction of GO and H2PtCl6 to rGO and PtNPs, respectively, without the 
need for any other reagents or thermal treatment.
As for graphene–nanoparticle composites composed of non-noble metal nanoparticles, Wu 
et al. recently deposited Cu nanoparticles on rGO and, more interestingly, investigated the 
mechanism underlying their electrochemical deposition (Figure 10).81 In their study, the 
nucleation of Cu on rGO was achieved using an electrolyte solution containing CuSO4 in a 
conventional three-electrode system, wherein the rGO electrode, a Pt mesh, and an Ag/AgCl 
electrode were used as the working, counter, and reference electrodes, respectively (Figure 
10A). To fundamentally study the nucleation of Cu on rGO via electrochemical deposition, 
the authors used CV, Tafel plots, and chronoamperometry. From CV, it was inferred that Cu 
deposition on rGO electrodes initiated at a more positive potential of 0.105 V (vs Ag/AgCl) 
as compared to that found for glassy carbon and pencil graphite. On the other hand, the Tafel 
plot confirmed that the rate-determining step for Cu deposition on rGO was mass transport 
and, finally, that nucleation on rGO occurred either instantaneously or progressively 
depending on the initial concentration of the electrolyte (e.g., instantaneously at higher 
concentrations [50 mM] and progressively at lower concentrations [10 mM]).
Last, although the vast majority of research efforts has concentrated on the electrochemical 
deposition of metal nanoparticles on graphene sheets, there have also been several reports of 
the electrochemical deposition of metal oxide nanoparticles onto graphene. For instance, Wu 
et al. deposited Cl-doped n-type Cu2O nanoparticles, which are abundant and nontoxic 
nanoparticles that have a direct band gap of ca. 2.0 eV,82 on rGO electrodes resulting in a 
carrier concentration of up to 1 × 1020 cm−3.83 Specifically, to deposit Cl–Cu2O 
nanoparticles on rGO, a solution of CuSO4, CuCl2, and lactic acid was added to a three-
electrode system where the rGO electrode, a Pt mesh, and SCE were used as the working, 
counter, and reference electrodes, respectively. The deposition used a potentiostatic process 
(potential of −0.4 V, charge density of 2 C cm−2) at a temperature of 60 °C. Similarly, ZnO 
nanorods could also be deposited on rGO films using a solution containing ZnCl2 and KCl 
as the supporting electrolyte in a conventional three-electrode system where an rGO-
polyethylene terephthalate electrode, a Pt mesh, and a SCE were used as the working, 
counter, and reference electrodes, respectively.84
2.2.4. Ex Situ Methods To Form Graphene–Nanoparticle Composites—
Graphene–nanoparticle composites can also be produced by the ex situ assembly of 
nanoparticles onto the graphene surface. In this method, the nanoparticles are synthesized in 
advance and then later attached to the surface of the graphene sheets via linking agents that 
can utilize either covalent or noncovalent interactions including van der Waals interactions, 
hydrogen bonding, π–π stacking, or electrostatic interactions. Although this method 
requires more time and steps to complete, it can offer a number of advantages when 
compared to in situ growth. For instance, ex situ methods result in a significantly narrower 
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size distribution as well as better control over the size, shape, and density of the 
nanoparticles that decorate the graphene sheets while utilizing self-assembly.85
For the covalent attachment of nanoparticles, GO rather than rGO is preferred due to the 
large amount of oxygen-containing groups on its surface, which can facilitate linkage with 
other functional groups. A variety of nanoparticles have been attached to graphene using this 
method. Fan et al. covalently attached MNPs to GO by first modifying the Fe3O4 
nanoparticles with tetraethyl orthosilicate and (3-aminopropyl)triethoxysilane (APTES), 
thereby introducing amino groups on its surface.86 Next, these amino groups were reacted 
with the carboxylic groups on the surface of GO with the aid of 1-ethyl-3-(3-
(dimethylamino)propyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS), resulting in 
the formation of GO-Fe3O4 nanoparticle composites. Moreover, they demonstrated that the 
GO could subsequently be reduced to rGO using NaBH4 as the reducing agent. Similarly, 
cadmium sulfide (CdS) QDs have been immobilized covalently on GO nanosheets.87 In this 
case, amino-functionalized CdS QDs were first prepared by modification of the kinetic 
trapping method.88 Next, GO nanosheets were aceylated with thionyl chloride to introduce 
acyl chloride groups on its surface. To covalently bond the QDs to the GO nanosheets, an 
amidation reaction between the amino groups on the QDs and the acyl chloride groups on 
the GO surface was performed. Finally, noble metal nanoparticles such as AuNPs have also 
been covalently attached to graphene. Specifically, Ismaili and co-workers demonstrated the 
light-activated covalent formation of AuNPs on rGO.89 In this study, 4 nm AuNPs were 
modified with a 3-aryl-3-(trifluoromethyl)-diazirine functionality. Correspondingly, upon 
irradiation with wavelengths above 300 nm and in the presence of rGO, the terminal 
diazirine group lost nitrogen to generate a reactive carbene that could then undergo addition 
or insertion reactions with the functional groups on graphene leading to covalent linkage.
Alternatively, nanoparticles can be attached to graphene sheets via noncovalent bonds 
including van der Waals interactions, hydrogen bonding, π–π stacking, and electrostatic 
interactions. Among these noncovalent bonds, π–π stacking and electrostatic interactions 
have been the most widely used. For π–π stacking, generally, aromatic compounds are 
attached to the nanoparticle surface, which enables their attachment to graphene via π–π 
stacking. For example, derivatives of the pyrene molecule as well as pyrene-functionalized 
block copolymers have provided an effective way for the noncovalent functionalization of 
carbon nanomaterials including graphene.90 In particular, pyrene groups have the ability to 
interact strongly with the basal plane of graphene via π–π stacking. For example, 1-
pyrenebutyric acid (PBA) is one of the simplest pyrene-containing molecules that are 
attached to a carboxyl group. Resultantly, graphene sheets functionalized with PBA become 
negatively charged allowing for the attachment of positively charged nanoparticles via 
electrostatic interaction.91 The use of pyrene-containing molecules has been reported for 
various nanoparticles. Examples include PBA, which was used to form graphene–AuNP 
hybrids,29c and pyrene-grafted poly(acrylic acid), which was used to form graphene–CdSe 
nanoparticle hybrids.92 Pyridine is another aromatic structure that has also seen significant 
use in anchoring nanoparticles such as Au44b,93 and CdSe94 nanoparticles to the basal planes 
of GO/rGO sheets via π–π stacking. Importantly, pyrene- or pyridine-modified graphene 
sheets have a high loading capacity for nanoparticles, and the amount of nanoparticle that 
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assembles on the graphene sheets can easily be modulated by controlling the feeding weight 
ratio of both components.29c
DNA molecules, which contain both purine and pyrimidine bases, have also been used to 
mediate the fabrication of graphene–nanoparticle composites. In particular, DNA is able to 
interact with graphene via π–π stacking interactions as well as the surface binding model 
wherein DNA electrostatically interacts with graphene basal planes, which is similar to what 
is observed between single-stranded DNA (ssDNA) and CNTs.95 For instance, Liu et al. 
developed a strategy wherein thiolated DNA oligos (d(GT)29SH) were first adsorbed onto 
GO sheets (DNA–GO) and then reduced by hydrazine to obtain DNA–rGO sheets.96 
Consequently, the addition of a large excess of 6 nm AuNPs to a solution containing either 
DNA–GO or DNA–rGO resulted in the formation of GO–AuNP and rGO–AuNP 
composites, respectively. Similarly, Wang et al. fabricated GO–AuNP and GO–AgNP 
composites by first functionalizing AuNPs or AgNPs with DNA via didentate capping 
ligands and then assembling them onto GO via π–π stacking interactions.97
As mentioned previously, electrostatic interactions are also commonly used to modify 
graphene with various nanoparticles as it provides a facile and scalable method to form 
composite structures in a controlled manner while avoiding conglomeration. GO and rGO 
have an inherent negative charge as a result of the ionization of the oxygen functional groups 
on their surface. As such, they can be decorated with positively charged inorganic 
nanoparticles through electrostatic interactions. For instance, graphene–metal oxide 
nanoparticle composites (e.g., rGO–Fe3O4 nanoparticle composites98 and GO–MnO2 
nanoparticle composites99) have been formed by mixing positively charged metal oxide 
nanoparticles with negatively charged graphene nanosheets.98 Similarly, graphene–noble 
metal and other inorganic nanoparticles have also been prepared in this way. To this end, Lu 
et al. noncovalently decorated GO sheets with positively charged aerosol Ag nanocrystals 
that were synthesized from an arc plasma source using an electrostatic force-directed 
assembly technique.100 Moreover, reports have decorated graphene with APTES-modified 
Si nanoparticles.101 Specifically, while the amine functional groups of APTES can function 
to reduce GO and form covalent bonds with rGO, APTES can also help disperse rGO and Si 
nanoparticles due to polar–polar interactions.
Finally, Deng and co-workers utilized a novel nontoxic synthetic method wherein bovine 
serum albumin (BSA) was utilized for the fabrication of graphene–nanoparticle composites 
that could be composed of various types of nanoparticles (Au, Pt, Pd, Ag, and polystyrene 
beads).102 In this study, the use of BSA not only effectively reduced GO to rGO, but also 
acted as a stabilizer to induce the attachment of nanoparticles onto the graphene surface 
(Figure 11A). Specifically, BSA–GO/rGO conjugates were first obtained via the adsorption 
of BSA onto the basal planes of GO/rGO. Afterward, the nanoparticles were mixed in a 
solution containing the BSA–GO/rGO conjugates overnight to form the final graphene–
nanoparticle composites. Moreover, the density of nanoparticles on the graphene–
nanoparticle composites could be controlled by simply changing the concentration of BSA 
and NaCl during assembly (Figure 11B–D). Similarly, Wang et al. recently reported an 
inexpensive and unique green synthetic method for the production of Ag–GO 
nanocomposites that utilized glucose as both the reducing and the stabilizing agent, 
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eliminating the need for toxic reduction agents.103 In particular, Wang and co-workers 
demonstrated that AgNPs could be directly reduced from silver ions on GO in a glucose 
solution.
2.3. Graphene-Encapsulated Nanoparticles
Because of the flexible and 2D sheet-like nature of graphene and its derivatives, these sheets 
can easily be used to wrap or encapsulate nanoparticles that range in diameter from 100 nm 
to several hundreds of nanometers and even micrometers (Figure 12). rGO sheets are the 
most frequently utilized carbon material for the encapsulation of nanoparticles due to their 
slightly hydrophilic nature and the ease with which small fractions of rGO can be fabricated. 
In particular, methods used to fabricate graphene-encapsulated nanoparticles typically utilize 
noncovalent bonds. For instance, the most frequently used method to encapsulate 
nanoparticles with rGO consists of endowing the surface of the nanoparticle with a positive 
charge (e.g., by coating with APTES), resulting in the strong attachment of rGO via 
electrostatic interaction.101b,104 By controlling the size of cracked rGO, a variety of 
nanomaterials such as polymer as well as inorganic, metals, and metal oxide nanoparticles 
can be encapsulated by graphene/rGO to enhance their properties as well as to obtain 
additional advantages.
In terms of its benefits, the encapsulation of nanoparticles with graphene endows similar 
enhancements in electrical, electrochemical, and optical properties that were observed for 
graphene–nanoparticle composites. However, due to the characteristically strong negative 
charge of rGO, the encapsulation of small nanoparticles with rGO also results in the 
suppression of aggregation, which is a major issue in many nanoparticle-based 
bioapplications.96,105 Moreover, because of the high degree of contact that exists between 
graphene and the encapsulated nanoparticle, which is significantly greater than that seen in 
graphene–nanoparticle composites, graphene-encapsulated nanoparticles are very stable, 
thereby limiting the degree of exfoliation of the nanoparticles from graphene or vice versa.
11c
Numerous reports have demonstrated the encapsulation of metal oxide nanoparticles with 
graphene. For example, Yang et al. reported rGO-encapsulated cobalt oxide nanoparticles 
(Co3O4). These rGO-encapsulated Co3O4 nanoparticles exhibited a very high reversible 
capacity (1000 mA h g−1) over 130 cycles, which was superior to normal cobalt oxide 
nanoparticles used for capacitors.104 In particular, using alternating current impedance 
measurements (30 cycles), Nyquist plots were obtained wherein the diameter of the 
semicircle for rGO-encapsulated Co3O4 electrodes in the high–medium frequency region 
was much smaller than that of bare Co3O4 electrodes. This suggested that the rGO-
encapsulated Co3O4 electrodes possessed lower contact and charge-transfer impedances. 
Feng and co-workers also reported graphene-encapsulated TiO2 nanospheres for efficient 
photocatalysis due to their high specific surface area (133 m2 g−1). Specifically, the resulting 
hybrid material was much more efficient at decomposing rhodamine B (91%) than normal 
TiO2 (65%) due to the presence of graphene, which was beneficial for the separation of 
photogenerated electrons and holes.106 Similarly, the performance of tin oxide (SnO2) 
nanoparticles was also improved by encapsulation of individual aggregates with graphene, 
Yin et al. Page 13
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
resulting in excellent performance including a charge capacity of 700 mA h g−1 at the 
current density of 0.1 A g−1 and 423 mA h g−1 after a 10-fold increase in the current density 
to 1 A g−1 in the 0.005–2 V voltage window.107 Finally, Lin and coworkers recently created 
rGO-encapsulated amine-functionalized Fe3O4 MNPs that were used to support Pt catalysts.
108
 Specifically, after the Fe3O4 nanoparticles were functionalized with APTES and coated 
with rGO, PtNPs were uniformly anchored by a polyol reduction reaction and the GO was 
simultaneously reduced to rGO. Resultantly, the electrochemical activity of the catalyst for 
methanol oxidation was significantly improved. The authors claimed that this was due to the 
accessibility of the PtNPs on the graphene surface and the greatly enhanced electronic 
conductivity of the underlying rGO-encapsulated Fe3O4 nanoparticles.
Others have focused on encapsulating metal nanoparticles with graphene. For instance, 
Zhang et al. recently reported an interesting material, a “graphene-veiled gold 
nanostructure”. In this study, they used graphene as a passivation nanosheet to prevent 
metal–molecule chemical interactions and to control the spatial resolution of molecules to 
achieve sensitive SERS signals from analytes of interest.16 Kawasaki and co-workers have 
also reported graphene-encapsulated cobalt nanomagnets, wherein the cobalt nanoparticles 
were first functionalized with benzylamine groups.109 These 30 nm graphene-encapsulated 
nanoparticles had a high specific surface area of 15 m2 g−1 and a high strength saturation 
magnetization of 158 emu g−1, which led to efficient extraction of analytes by magnetic 
separation for surface-assisted laser desorption/ionization mass spectrometry (affinity 
SALDI-MS) analysis.
In addition to the above examples, our group recently reported a method to convert 
nonconducting silicon oxide nanoparticles into conducting rGO-encapsulated nanoparticles, 
which could then be used as the “bridging-material” in a field-effect transistor (FET)-based 
biosensor.101b,110 Specifically, SiO2 nanoparticles were functionalized with APTES thereby 
imparting them with a positive surface charge, which allowed for encapsulation with rGO 
via electrostatic interaction (Figure 12). In doing so, we were able to prevent aggregation 
while maintaining a high electrical conductivity and enhanced surface area for the detection 
of cancer markers. Similarly, Zhou et al. also encapsulated Si nanoparticles with rGO via 
electrostatic interaction, again using APTES.111 As a consequence of encapsulation, the Si 
nanoparticles exhibited less aggregation and destruction than pristine SiNPs and acted as an 
outstanding electrode, exhibiting high reversible capacity (902 mA h g−1 after 100 cycles at 
300 mA g−1). On the other hand, pristine SiNPs exhibited an initial discharge capacity of 
3220 mA h g−1, which dropped to 13 mA h g−1 after only 50 cycles.
Finally, while electrostatic interaction has been the most commonly used method to form 
graphene-encapsulated nanoparticles, Luo et al. reported an innovative method to fabricate 
graphene-encapsulated nanoparticles via a facile and scalable, capillary-driven aerosol 
droplet method. Specifically, in a typical experiment, Si nanoparticles in an aqueous 
suspension were directly added to a dispersion of micrometer-sized GO sheets. Nebulization 
of the colloidal mixture resulted in the formation of aerosol droplets, which were blown 
through a preheated tube furnace at 600 °C with a N2 carrier gas (Figure 13A). As a result, 
during the process of evaporation, the amphiphilic GO sheets migrated to the surface of the 
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droplets to form a shell, and as the droplets evaporated further, the GO shell collapsed 
forming a “crumpled” shell around the Si nanoparticles (Figure 13B).112
3. GRAPHENE–NANOPARTICLE HYBRID MATERIALS FOR BIOSENSING 
APPLICATIONS
Biosensors are analytical devices that utilize biological sensing elements to detect and/or 
quantify a particular target analyte or family of analytes. As such, biosensors are applicable 
to and are important for virtually every conceivable analytical task in the biomedical field, 
which can range from applications in medical diagnostics to drug discovery, food safety, 
environmental monitoring, and defense.
In general, biosensors are composed of two fundamental elements: a receptor and a 
transducer. The receptor consists of any material, either organic or inorganic, that can 
interact with a target analyte or family of analytes. On the other hand, the transducer 
converts the recognition event that occurs between the analyte and the receptor (e.g., the 
binding of an enzyme to its substrate, binding between an antibody and its target protein, or 
reduction/oxidation of an electroactive biomolecule by the sensing electrode) into a 
measurable signal that can come in many forms including, but not limited to, electronic, 
electrochemical, and optical signals. In terms of its performance, biosensors are evaluated on 
the basis of sensitivity to the target(s), limit of detection (LOD), linear and dynamic ranges, 
reproducibility or precision of its response, and selectivity.113 Other parameters that are 
often compared and useful include the sensor’s response time (e.g., the amount of time 
needed for the sensor response to reach 95% of its final value after introduction of the 
analyte(s)), operational and storage stability, ease of use, and portability. Moreover, the ideal 
biosensor should be reusable, thereby allowing for several consecutive measurements to be 
made.
Graphene–nanoparticle hybrids are particularly well-suited for biosensing applications. As 
mentioned previously, graphene possesses numerous unique and advantageous 
physicochemical properties including an extremely high surface area, excellent electrical 
properties, high mechanical strength, advantageous optical properties (e.g., transparent and 
can quench fluorescence), and is relatively easy to functionalize and mass produce. As such, 
there has been significant effort invested in utilizing this material for the development of 
biosensors.9a,114 Moreover, nanoparticles have also been widely investigated in the field of 
biosensing due to the exquisite sensitivity that nanomaterials can offer for this type of 
application.115 Specifically, because of the diameter of nanoparticles (e.g., 1–100 nm scale), 
these nanomaterials can display unique physical and chemical features (e.g., quantum size 
effect, surface effect, and macro-quantum tunnel effect). As such, nanoparticles can be used 
to enhance achievable sensitivities by amplifying the obtained signal as well as increasing 
the available surface area for analyte binding.
By combining these two excellent and unique modalities as graphene–nanoparticle hybrids, 
a number of advantageous properties are attained for biosensing applications. In particular, it 
has been observed that graphene acts as an excellent material with which to immobilize 
nanoparticles and enhance their stability (e.g., preventing aggregation). Moreover, the 
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combination of graphene with nanoparticles can increase the available surface area for 
analyte binding as well as improve their electrical conductivity and electron mobility, 
thereby enhancing the achievable sensitivity and selectivity.11a In particular, the field of 
graphene–nanoparticle hybrid materials for biosensing applications can be generally divided 
into three classes based on the underlying mechanism of detection. These classes include (1) 
electronic, (2) electrochemical, and (3) optical sensors, with each class having its own 
advantages and disadvantages. As such, in this section, we will give a comprehensive review 
of recent work that has been conducted on the development of graphene–nanoparticle hybrid 
biosensors. In particular, we will focus primarily on the use of graphene–nanoparticle hybrid 
materials in electronic (e.g., FET), electrochemical, and optical biosensors, with emphasis 
on how they compare to current gold standards and their achievable sensitivities and 
selectivities for various biomolecules (Table 2).
3.1. Electronic Sensors
As compared to the other methods that are available for biosensing applications, 
nanomaterial-based electronic biosensing offers significant advantages, such as high 
achievable sensitivities, high spatial resolution for localized detection, easy miniaturization, 
facile integration with standard semiconductor processing, and label-free, real-time detection 
that can be achieved in a nondestructive manner.116 In particular, these electronic sensors 
primarily utilize the principle of FETs to convert the biological recognition event to a 
measurable electronic signal. In a standard FET device, current flows along a semiconductor 
path (the channel) that connects two electrodes (the source and the drain). The conductance 
of the channel between the source and the drain is then switched on and off by a third 
electrode (the gate) that is capacitively coupled to the device through a thin dielectric layer.
116,117
 Specifically, in FET-based biosensors, the channel is in direct contact with the 
sensing sample, which enhances the achievable sensitivity as any single biological event that 
occurs at the channel surface could result in a variation in the surface potential thereby 
modulating the channel conductance.118
Currently, FET sensors that are composed of Si nanowires or carbon nanotubes (CNTs) are 
the most heavily investigated.118,119 FET sensors that utilize either of these materials exhibit 
exceptional performance with their achievable LOD falling in the range of picomolar (pM) 
to femtomolar (fM); however, the achievable sensitivity of devices that use these materials is 
limited by the rarity of binding events that occur between the probe and its target molecule 
due to the scarcity of available binding sites on the surface of the materials.116 Moreover, the 
use of Si nanowires is expensive. On the other hand, while CNT sensors represent a 
significantly cheaper option, the reproducibility of CNT-based devices in terms of their 
fabrication and electrical properties is considered a significant limiting factor.120 As such, 
graphene-based materials have a major advantage in FET sensing applications in that 
graphene has an extremely high surface-to-volume ratio, which increases the likelihood of 
binding events. In particular, graphene-based FET biosensors are able to compete with CNT 
and Si nanowire-based FET sensors with an ultrasensitive LOD down to a similar (pM to 
fM) and potentially lower range.121 More specifically, because of this high surface-to-
volume ratio, any analytes that adsorb onto the graphene surface could potentially alter its 
electronic properties (e.g., the conductivity can be altered when an analyte is adsorbed due 
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to doping or a change in the carrier mobility of graphene). In addition, by utilizing 
graphene–nanoparticle hybrid materials it is possible to further push this limit to the 
attomolar (aM) range for biomolecule detection by utilizing the synergism that occurs in 
these unique structures, wherein the combination of two materials results in additional 
surface area for analyte binding as well as signal amplification and enhanced electrical 
conductivity. For instance, Zhang et al. determined that the covalent linkage of AuNPs to 
GO could enhance the electronic conductivity when compared to GO alone.122 Similarly, 
Dinh and colleagues reported that the formation of rGO–AgNPs decreased the sheet 
resistance from 10.93 kΩ sq−1 (for rGO) to 270 Ω sq−1.123
Demonstrations utilizing graphene–nanoparticle hybrid-based FET biosensors have focused 
on exploiting variations of a single mechanism. Specifically, studies have shown that by 
conjugating the detection probe (e.g., antibody) to the nanoparticle and then using these 
nanoparticle–probe conjugates to form graphene–nanoparticle composites, one can preserve 
the superb electrical properties of graphene. In these cases, the formation of the graphene–
nanoparticle hybrid generally occurs via electrostatic interaction and van der Waals binding. 
As such, as long as detection probe conjugation does not significantly affect the charge of 
the nanoparticles, graphene–nanoparticle composites can be formed without any steric 
hindrance. One popular FET-based biosensing application that has utilized this concept is for 
the detection of proteins. Protein detection is particularly important as proteins play an 
essential role in all biological functions. As such, they are at the center of almost all 
pathological conditions, and the majority of disease markers are composed of proteins. Chen 
et al. reported the first graphene–AuNP hybrid sensor for the detection of proteins.124 In this 
case, thermally reduced GO sheets (TRGO) (e.g., a few layers with a thickness of 3–6 nm) 
were decorated with 20 nm AuNPs, which were covalently conjugated to anti-
immunoglobulin G (IgG) antibodies (Figure 14A). Upon introduction of the target protein 
(e.g., IgG), FET and direct current was measured resulting in a LOD of approximately 13 
pM (Figure 14B), which is among the best LODs when compared to carbon nanomaterial-
based protein sensors including CNTs,125 graphene, and GO.126 This sensor also showed 
excellent selectivity when exposed to samples containing mismatched protein such as 
immunoglobulin M (IgM) or horseradish peroxidase (HRP). In particular, when 0.8 mg mL
−1
 IgM and 0.2 mg mL−1 HRP were introduced to the sensor using the exact procedure as 
that used for IgG, the sensor response was 15.3% and 12.4%, respectively, which was 
significantly lower than that from the complementary IgG (68.0%). Last, it was observed 
that binding of the IgGs to their anti-IgGs resulted in local geometric deformations and an 
increase in the number of scattering centers across the sheet, thereby reducing the mobility 
of holes and, subsequently, the conductivity of the TRGO sheets.
Besides preserving the excellent electrical properties of graphene, graphene–nanoparticle 
composites also exhibit additional advantages such as increasing available surface area for 
the binding of target analyte, enhanced stability, and also amplified transduction signals.127 
For example, Kwon et al. reported a novel liquid-ion gated FET using large-scale graphene 
micropattern nanohybrids decorated with closely packed conducting polymer nanoparticles 
for the detection of HIV.127a Specifically, this closely packed nanoparticle array was 
composed of 20 nm carboxylated polypyrrole nanoparticles that were covalently modified 
with HIV-2 gp36 antigen and provided an enlarged surface area and stable sensing geometry. 
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Therefore, the authors could detect the HIV biomarker at concentrations as low as 1 pM, 
which is better than any biosensor that has been reported for this particular purpose. 
Moreover, this biosensor exhibited excellent mechanical flexibility and durability. On the 
other hand, Kim and coworkers demonstrated that, in addition to preserving the superb 
electrical properties of graphene and increasing available surface area, graphene–
nanoparticle hybrids could also be designed to amplify the transduction signal, thereby 
further increasing the achievable LOD by a full order of magnitude.127b In this work, the 
authors fabricated a FET biosensor that had networked channels of chemically reduced GO 
nanosheets, which were modified with aptamers specific for the detection of anthrax toxin 
(e.g., protective antigen) (Figure 15A). Briefly, in their design, the source/drain electrodes 
were formed on a networked film composed of rGO nanosheets using a shadow mask to 
prevent the deposition of polymeric residues during photolithography. Next, passivation of 
the electrodes was achieved with a 200 nm thick Al2O3 layer and direct pasting with PDMS, 
which minimized local work function modulation and isolated the leakage current between 
the electrode and electrolytes. In this way, Kim et al. achieved an ultralow LOD of 12 aM in 
10 μM PBS. Furthermore, by utilizing secondary aptamer-conjugated AuNPs, they were able 
to achieve an even lower LOD of 1.2 aM (Figure 15B). This was attributed to the ability of 
the secondary aptamer-conjugated AuNPs to further amplify the transduction signal. As for 
the achievable selectivity, the authors exposed their sensor to a PBS solution containing 
carcinoembryonic antigen (CEA). The results showed no shift in voltage and no change in 
current, indicating that no CEA binding occurred.
As a variation of the above-mentioned mechanism, encapsulating nanoparticles with 
graphene can also enhance the surface-to-volume ratio that is available for the capture of 
target analyte in FET sensors while enhancing stability. Recently, our group developed an 
rGO encapsulated nanoparticle-based FET sensor for the sensitive and selective detection of 
proteins (Figure 16).101b In particular, we sought to detect human epidermal growth factor 
receptor 2 (HER2) and epidermal growth factor receptor (EGFR), which are both known to 
be overexpressed in breast cancers.128 To this end, individual silicon oxide nanoparticles 
(100 nm diameter) functionalized with APTES were coated with a thin layer of rGO (5 nm 
thick) due to the electrostatic interaction that could occur between the negatively charged 
GO sheets and the positively charged silicon oxide nanoparticles. Arrays of rGO 
nanoparticles (rGO-NP) were then patterned to form channels between gold electrodes, 
which occurred through a self-assembly process upon centrifugation of the device with a 
solution containing rGO–NPs (Figure 16A). Finally, the rGO–NPs were functionalized with 
monoclonal antibodies against HER2 or EGFR (Figure 16B). Specifically, this was 
accomplished using a well-established process where the rGO surface was functionalized 
with 4-(pyren-1-yl)butanal via π–π stacking. Next, the aldehyde groups were coupled to the 
amine groups of the HER2 or EGFR antibodies through reductive amination and unreacted 
aldehyde groups were blocked using ethanolamine. In this way, we were able to preserve the 
electrical properties of the rGO by not conjugating the antibodies directly to the rGO surface 
while increasing the available surface area available for detection over rGO alone. Using this 
device, we were able to achieve a detection limit as low as 1 pM for HER2 and 100 pM for 
EGFR (Figure 16D–F). In addition, we demonstrated the highly selective nature of our 
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biosensor in the presence of other proteins such as BSA (50 μg mL−1), which did not induce 
a change in conductance.
Finally, besides proteins, the detection of specific nucleic acids (e.g., DNA or RNA) has 
garnered significant attention as it can be utilized for various bioapplications including, but 
not limited to, pathogen identification, the recognition of genetic mutations, and forensic 
analysis.129 For instance, Yin and coworkers reported a PtNP-decorated rGO FET where a 
thiolated DNA probe was attached to the PtNPs via Pt–S bonding.130 Specifically, a large, 
continuous, few-layer thick film of GO was fabricated via the Langmuir–Blodgett method 
and subsequently reduced with high temperature annealing in an Ar/H2 atmosphere at 
1000 °C. To form graphene–nanoparticle composites, the PtNPs were directly synthesized 
on the rGO film by immersion of the rGO in an ethanolic solution of PtCl4 followed by light 
irradiation. It was found that this graphene–nanoparticle composite-based FET, when 
modified with probe DNA, was able to detect the real-time hybridization of target DNA in 
PBS with a calculated detection limit of 2.4 nM. Moreover, the sensor exhibited good 
selectivity. For instance, when 1 μM of noncomplementary DNA was added to the sensing 
chamber, there was no obvious change in the conductance.
Overall, the performance of hybrid electronic sensors depends strongly on graphene 
morphology (e.g., wrinkles, folds, number of layers), the number of graphene sheets, the 
level of graphene reduction, and the interface that exists between the nanoparticles and 
graphene, which can all influence the electrical properties of the device. In particular, the 
morphology (e.g., wrinkles, folds, number of layers) of graphene should be free of defects 
and, as such, hinges on the synthesis method used. On the other hand, the nanoparticle–
graphene interface is highly susceptible to modulations by adsorbed species, and the 
Schottky barrier of the interface has been shown to significantly change device conductance.
124
 In particular, smaller sized nanoparticles can be distributed more uniformly on graphene 
materials and provide more contact area than bigger sized nanoparticles, resulting in an 
improvement in electrical properties.123
3.2. Electrochemical Sensors
Electrochemical sensors are, by far, the largest group of sensors and provide an especially 
attractive means with which to analyze the content of a biological sample due to the direct 
conversion of a biological recognition event to an electrical signal. A typical electrochemical 
sensor consists of a sensing (or working) electrode that has a biological recognition element 
and a counter electrode that are separated by a layer of electrolytes. Electrochemical 
biosensors can be divided into two main categories based on the nature of their biological 
recognition process: (1) affinity-based sensors and (2) catalytic sensors. Affinity sensors rely 
on the selective binding interaction that occurs between a biological component such as an 
antibody, enzyme, nucleic acid, or a receptor (e.g., immunosensor or DNA hybridization 
biosensor) and its target analyte, which results in the production of a measurable electrical 
signal. On the other hand, catalytic sensors generally incorporate nanoparticles or enzymes 
that recognize the analyte of interest and produce electroactive species. The amount of 
analyte that is either reduced or oxidized at the sensing electrode would then correlate with 
the concentration of the target analyte present. In particular, various forms of voltammetry 
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(e.g., linear sweep, differential pulse, squarewave, stripping) and amperometry are 
commonly used for the electrochemical detection of biomolecules.131
Graphene is an ideal material for electrochemical biosensors as it is an excellent conductor 
of electrical charge.9a Moreover, because of its high surface area, graphene can facilitate a 
large number of defects and thus electroactive sites.132 The electrochemical behavior of 
graphene is also excellent and comparable to other carbon-based materials including CNTs 
and graphite where recent reports have even demonstrated that graphene-based 
electrochemical sensors have superior performance when compared to CNTs due to the 
presence of more sp2-like planes and edge defects on the surface of graphene.133
While graphene exhibits great promise, graphene–nanoparticle hybrid structures have 
recently gained increasing attention for their applicability to electrochemical sensing. In 
particular, various types of nanoparticles, including metal nanoparticles such as Au and Pt, 
metal oxide nanoparticles, and semiconductor nanoparticles, are already widely used for 
electrochemical sensing applications.115a,134 These nanoparticles can have different roles in 
electrochemical sensing platforms; for example, they can function to (1) immobilize 
biomolecules, (2) catalyze electrochemical reactions, or (3) act as a reactant. As such, by 
incorporating graphene–nanoparticle hybrid structures, one can impart unique and 
advantageous properties to electrochemical biosensors resulting in the exhibition of the 
advantages provided by the individual nanoparticle and graphene components as well as 
synergy from the hybrid. For example, graphene sheets that are decorated with nanoparticles 
can help overcome the poor utilization coefficient of aggregated nanoparticles.48d In certain 
cases, by decorating graphene with nanoparticles, one can also efficiently improve the 
electron transfer that occurs between the analyte and the electrode.135 Finally, similar to the 
strategy that was used in some hybrid FET sensors, instead of immobilizing the sensing 
biomolecules directly to graphene, which is often difficult and can negatively affect 
electrical properties, graphene–nanoparticle hybrids can be formed wherein the sensing 
biomolecules are first immobilized on the nanoparticles prior to decoration onto graphene. 
As a result, this can enhance the achievable sensitivity of graphene–nanoparticle hybrid 
electrochemical sensors.
In the following subsections, we will focus on graphene–nanoparticle hybrid structures for 
the immobilization of biomolecules and the catalysis of electrochemical reactions. Emphasis 
will be placed on the different biological applications that they can be used for and the 
advantages and disadvantages that they provide. Finally, a comparison between graphene–
nanoparticle hybrid-based electrochemical sensors and electrochemical sensors that use 
other more established materials will also be provided throughout.
3.2.1. Immobilization of Biomolecules—Because of its large specific surface area, 
graphene–nanoparticle hybrids are advantageous for the immobilization of biomolecules. 
Moreover, the excellent electrical properties of graphene significantly improve the electronic 
and ionic transport capacity of the resulting hybrid electrochemical sensor, thereby 
enhancing achievable sensitivities and measurement ranges. Specifically, efforts to apply 
graphene–nanoparticle hybrids to the immobilization of biomolecules have primarily 
focused on utilizing enzymes, antibodies, and DNA with enzymes being the most common.
Yin et al. Page 20
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
There have been numerous reports demonstrating the graphene–nanoparticle hybrid-based 
immobilization of enzymes for electrochemical detection. Specifically, the mechanism of 
action is based on utilizing enzymes that catalyze redox reactions. In this case, when the 
immobilized enzyme catalyzes a redox reaction of the target analyte, a direct electron 
transfer from the enzyme to the electrode occurs, which provides an amperometric signal 
that is proportional to the concentration of analyte.136 For example, Shan et al. gave the first 
report of an electrochemical biosensor based on a graphene–AuNP nanocomposite for the 
detection of glucose.137 In this instance, the enzyme glucose oxidase, which reduces O2 into 
H2O2 in the presence of glucose, was immobilized in thin films consisting of a graphene/
AuNP/chitosan nanocomposite on a gold electrode. Specifically, chitosan was an ideal 
candidate for the immobilization of bioactive molecules onto the electrodes as it has 
excellent biocompatibility and film-forming ability.138 The resulting composite film had a 
LOD of 180 μM for glucose. Moreover, the sensor exhibited good reproducibility (4.7% 
standard deviation for six successive measurements) and an amperometric response to 
glucose with a linear range from 2 to 14 mM, which is a suitable range for the clinic as the 
blood glucose level of normal people range from 4 to 6 mM. In terms of the selectivity, 
glucose (2.5–7.5 mM) could be reproducibly detected in real blood samples. All of this was 
a result of the synergistic effect that occurred in the graphene–AuNP hybrid structure, where 
the presence of graphene in the nanocomposite film improved the electronic and ionic 
transport capacity, resulting in a considerable enhancement in its electrocatalytic activity 
toward H2O2 when compared to AuNPs alone.139
Another enzymatic electrochemical sensor utilizing hybrid structures for the detection of 
glucose was reported by Gunasekaran and co-workers.140 In this work, a green, simple, fast, 
and controllable approach was developed in which a novel nanocomposite consisting of 
electrochemically reduced GO (ERGO) and gold–palladium (1:1) nanoparticles (AuPdNPs) 
was synthesized in the absence of reducing agents. Bimetallic nanoparticles are 
advantageous, especially for electrocatalysis, due to their ability to enhance electrocatalytic 
activity, improve biocompatibility, promote electron transfer, and poison resistance.141 In 
particular, Pd is one of the most frequently used electrocatalysts to facilitate reduction 
reactions involving oxygen, while the introduction of Au into the hybrid offers many 
appealing properties such as improved biocompatibility and provides an excellent surface for 
biofunctionalization with biomolecules that contain primary amine groups.142 Glucose 
oxidase was then immobilized as a model enzyme to detect O2 consumption that occurs 
during the enzymatic reaction of glucose oxidase in the presence of glucose. While 
quantifying the electrochemical properties of the ERGO–AuPdNP nanocomposites using 
electrochemical impedance spectroscopy, it was determined that the charge transfer 
resistance drastically decreased when ERGO was functionalized with metal nanoparticles. 
(49.0, 108.9, and 39.6 Ω for Au, Pd, and AuPd nanoparticles, respectively). This result 
demonstrated that AuPdNPs had a better electron-transfer interface with the electrode 
surface, the electrolyte solution, and also between the electroactive sites of the immobilized 
enzyme and electrode when compared to pure metal nanoparticles. Importantly, the resulting 
ERGO–AuPdNP nanocomposite-based electrochemical sensor exhibited excellent 
biocompatibility and had a LOD of 6.9 μM, a linear range up to 3.5 mM, and a sensitivity of 
266.6 μA mM−1 cm−2. Last, in terms of its selectivity, the device could be used to measure 
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glucose in clinical blood samples, where its detection ability was only ±10% different from a 
clinical Roche Modular Chemistry Analyzer.
The immobilization of other biomolecules such as DNA and antibodies has also been 
demonstrated with great success. In the case of antibody immobilization (e.g., 
immunosensor), a trace antibody is labeled with an electroactive species, such as an enzyme, 
metal nanoparticle, or QD. As such, when a potential is applied, the concentration of the 
analyte can be quantified by measuring the resulting current at the electrode.131 Using this 
principle, Qi et al. recently developed a sensitive Pd-rGO-based label-free electrochemical 
immunosensor for the detection of the hepatocellular carcinoma biomarker alpha fetoprotein 
(AFP).143 Specifically, a glassy carbon electrode (GCE) was first coated with Pd–rGO, 
where the Pd nanoparticles were 4–8 nm in diameter (Figure 17A). Afterward, the anti-AFP 
antibody solution was added onto the electrode surface. The mechanism of the resulting 
immuno-sensor was based on the formation of antigen antibody immunocomplexes on the 
surface of the electrode, which was coated with Pd–rGO. The decrease in the resulting 
amperometric current of H2O2 was then directly proportional to the concentration of AFP 
present. As such, the LOD of the immunosensor for AFP was 5 pg mL−1 and was found to 
have a linear range from 0.01 to 12 ng mL−1 (Figure 17B). They were also able to use this 
immunosensor to determine AFP in clinical serum samples and demonstrated that the 
devices offered good stability, biocompatibility, as well as a large surface area. In terms of 
its selectivity, the device was exposed to several biomolecules found in serum, including 
BSA (60 000 000 ng mL−1), L-lysine (30 000 ng mL−1), ascorbic acid (2000 ng mL−1), and 
dopamine (150 ng mL−1), in the presence and absence of 1 ng mL−1 AFP. It was found that 
the peak current in these cases differed by less than 6%. Similarly, Lu et al. developed a 
facile and sensitive electrochemical immunosensor for the detection of human chorionic 
gonadotrophin (hCG), which is secreted from the placenta during pregnancy and from 
patients with gestational trophoblastic diseases. In this device, they constructed an 
electrochemical immunosensor using AuNP decorated CNT–graphene composites.144 As a 
result of the larger surface area available to capture the primary antibody and, subsequently, 
the analyte of interest as well as improvements in the electron transmission rate, the as-
prepared immunosensor had an exceptional linear response range from 0.005 to 500 mIU 
mL−1 with a low LOD of 0.0026 mIU mL−1 and also proved sensitive, selective, stable, and 
reproducible for the detection of hCG from human serum samples. Moreover, the 
immunosensor maintained a relative standard deviation of only 1.12–2.45% when hCG was 
detected in the presence of interfering biomolecules such as CEA, AFP, cancer antigen 125, 
prostate-specific antigen, and BSA, further demonstrating its selectivity.
Last, as mentioned previously, the accurate and rapid detection of DNA has received 
significant attention due to its important role in the diagnosis of genetic diseases including 
Alzheimer’s disease and various cancers. As such, effort has been invested in the 
development of DNA-based electrochemical sensors (e.g., genosensor), which utilize a 
mechanism similar to that stated above for immunosensors. To this end, Lin and co-workers 
reported an electrochemical DNA sensor wherein the captured DNA was directly 
immobilized on the surface of a graphene-modified GCE through π–π stacking (Figure 
18A).145 AuNPs modified with oligonucleotide probes were then cohybridized on the GCE 
surface in a sandwich assay format for the detection of the targeted DNA sequence. By 
Yin et al. Page 22
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
utilizing graphene–nanoparticle composite structures, Lin et al. demonstrated enhanced 
analytical performance with a linear range from 200 pM to 500 nM, and a low LOD of 72 
pM due to the higher electron transfer resistance and peak current of the composite structure 
as compared to graphene alone. Moreover, the biosensor could discriminate the target 
complementary sequence from single-base pair mismatches (Figure 18B). On the other 
hand, Du et al. utilized graphene–mesoporous silica–AuNP hybrids (GSGHs) for the ultra-
sensitive and selective detection of DNA using strand-displacement DNA polymerization 
and parallel-motif DNA triplex as a dual amplification system.146 In this system, GSGH was 
synthesized through self-assembly, and the device was fabricated via layer-by-layer 
assembly on an ITO electrode (Figure 19A and B). In terms of the sensing mechanism, in 
the first stage, the target DNA strand acted as a trigger to initiate a polymerase chain 
reaction (PCR). This process resulted in strand migration along the template and production 
of a complementary strand that would then displace the target DNA, allowing the target 
strand to be reused. Next, the sensing interface was incubated with the duplex product 
resulting in the formation of triplexes between the duplex DNA and the single-stranded 
acceptor DNA attached on the sensor surface. This duplex blocked the electrode surface with 
a partially covered adsorption layer leading to a sharply decreased differential pulse 
voltammetry signal (Figure 19C). In this way, a very low LOD of 6.6 pM was achieved, 
which is 4 orders of magnitude lower than those of graphene-based DNA sensors coupled 
with fluorescent assays (100 pM to 1 nm) and 5 orders of magnitude lower than those of 
FET-based assays (1 and 2 nM) due to the combination of the advantages from the 
graphene–nanoparticle composites with those from the dual amplification system (Figure 
19E and F). This system also demonstrated excellent selectivity wherein the addition of 
mismatched DNAs containing single nucleotide polymorphisms resulted in only a 6.3–
22.2% decrease in the original signal (vs a 66.7% decrease for original target DNA).
3.2.2. Catalysis of Electrochemical Reactions—Sensors that utilize biomolecules 
such as enzymes, antibodies, and DNA have been widely used in electrochemical sensors as 
well as other sensor types, allowing users to achieve excellent sensitivity and selectivity. 
However, biomolecules are also associated with potential limitations such as poor long-term 
stability, high costs, and may require complicated immobilization procedures. Therefore, 
there has been increasing interest in the development of enzyme-free sensors as they are 
cheaper to produce, more stable, simpler to fabricate, and highly reproducible.113,147
For this purpose, there has been significant interest in nonenzymatic electrochemical sensors 
that utilize catalysis to directly detect electroactive biomolecules at the electrode surface. 
Graphene–nanoparticle hybrids, wherein metal nanoparticles (e.g., Pt, Au) are used, exhibit 
excellent catalytic properties for this purpose with the majority of such sensors being applied 
for the detection of neurotransmitters (e.g., AA, dopamine (DA), and uric acid [UA]), 
glucose and other carbohydrates, and hydrogen peroxide. In particular, the common 
detection principle in this case relies on amperometric detection, wherein the analyte of 
interest is oxidized or reduced (usually oxidized) at the sensing electrode (e.g., anode) when 
a potential is applied. In terms of the advantages that graphene–nanoparticle hybrids hold for 
this application, the introduction of metal nanoparticles into electrochemical sensors can 
decrease overpotentials that are typically seen with many electrochemical reactions. 
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Moreover, the graphene–nanoparticle hybrids have advantages that enhance the overall 
performance of such sensors as graphene provides an excellent supporting material to 
facilitate the immobilization and stabilization of nanoparticles on the electrode surface. 
Moreover, as mentioned previously, graphene–nanoparticle hybrids show high conductivity 
and enhanced electron transfer over nanoparticles alone and thus can greatly increase the 
achievable sensitivity and selectivity.
The detection of neurotransmitters such as AA, DA, and UA is a particularly significant 
application for biosensors. DA is an especially important neurotransmitter in the central 
nervous system. Low levels of DA have been shown to cause neurological disorders such as 
schizophrenia and Parkinson’s disease. As such, there is an urgent need for the accurate and 
rapid determination of DA in bodily fluids. However, this issue is confounded by the 
existence of AA and UA, which have oxidation potentials similar to those of DA but coexist 
with DA at concentrations that are several orders of magnitude higher. To address this issue 
and accurately detect DA and distinguish it from AA and UA, Sun et al. developed a 
graphene-PtNP-modified GCE.148 Specifically, size-selected PtNPs with a mean diameter of 
1.7 nm were self-assembled onto the graphene surface and incorporated as the working 
electrode in a standard three-electrode cell, where a silver/silver chloride and platinum 
electrode were used as the reference and counter electrodes, respectively. Measurements 
were then taken via CV and differential pulse voltammetry. Using this method, the 
graphene-PtNP-modified GCE was able to simultaneously detect the aforementioned three 
analytes via their oxidation peaks. In particular, according to the CV curves, the overlapping 
voltammetric peaks could be resolved into three, well-defined oxidation peaks at 
approximately 40 mV (AA), 225 mV (DA), and 369 mV (UA). In comparison to GCE and 
graphene alone, the hybrid electrode provided a significantly enhanced voltammetric peak 
separation and higher currents for all three analytes. Similarly, for PtNPs alone, peaks 
potentials were observed at 70 mV (AA), 190 mV (DA), and 330 mV (UA) due to the 
catalytic properties of Pt, however, with very low currents. Consequently, detection limits as 
low as 0.15, 0.03, and 0.05 μM are achieved for AA, DA, and UA, respectively. As such, the 
authors claimed that this electrode system could differentiate well between AA, DA, and UA 
due to the graphene support, which allowed for enhanced dispersion of PtNPs and thereby 
full utilization of their catalytic properties for the detection of these three neurotransmitters.
Besides neurotransmitters, there is also significant interest in the development of 
nonenzymatic biosensors for glucose and other carbohydrates as they are important in many 
areas such as clinical diagnostics (e.g., diabetes), medicine, and in the food industry. To this 
end, Luo et al. developed a novel enzyme-free glucose sensor based on graphene–Cu 
nanoparticle composites, which was synthesized by electrodepositing Cu nanoparticles on a 
graphene sheet-modified GCE.149 In particular, Cu was chosen as a sensing material on the 
basis of its wide usage in the amperometric detection of carbohydrates like glucose. As a 
result of its hybrid structure, the graphene–Cu nanoparticle electrode showed much better 
electrocatlytic properties for glucose oxidation and detection as compared to unmodified 
graphene electrodes and Cu/GC electrodes, as well as many other nonenzymatic glucose 
sensors that have been reported in the literature. Specifically, the authors found that when 
studying the electrodes with electrochemical impedance spectroscopy, the graphene–Cu 
nanoparticle electrodes had the lowest electron transfer resistance value (22 Ω) followed by 
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Cu electrodes (24 Ω) and graphene electrodes (28 Ω). This demonstrated the graphene–Cu 
nanoparticle electrode’s superior electrochemical activity, which the authors hypothesized 
was due to the synergy that existed between graphene and Cu, where the Cu nanoparticles 
act as an electron mediator in the electron transfer process. As such, the authors reported that 
the device was characterized by a linear response up to 4.5 mM and a very fast response 
time (<2 s). Importantly, the device could achieve a low LOD of 0.5 μM for glucose, which 
is superior to other devices reported for glucose sensing. Finally, in the presence of 
interfering species such as fructose, lactose, sucrose, AA, UA, and DA, the device exhibited 
a minimal change in current (0.2–4%) and could still respond strongly to glucose.
Similarly, Chen and co-workers have demonstrated electrodes utilizing graphene–copper 
nanoparticle150 and graphene–nickel nanoparticle151 hybrid structures for the enhanced 
electrochemical detection of carbohydrates when compared to nanoparticle systems alone 
(Figure 20). In these studies, copper and nickel were chosen on the basis of their wide usage 
in the amperometric detection of carbohydrates and their strong electrocatalytic activity with 
regard to the oxidation of carbohydrates in alkaline solutions, respectively. In the case of the 
graphene–copper nanoparticle hybrid sensor, the hybrid structures were packed into fused 
silica capillaries to form microdisc electrodes (Figure 20A and B).150 In the presence of 2.0 
mM glucose, CV indicated that the peak current for the oxidation of glucose on the 
graphene–copper nanoparticle composite packed electrode was much higher than that on the 
copper nanoparticle electrode alone (+0.65 V). In particular, the authors suggested that the 
deposition of copper nanoparticles on graphene sheets with high specific surface area 
resulted in higher elecrocatalytic activity due to improved electron transduction. To 
demonstrate its performance, the graphene–copper nanoparticle composite packed electrode 
was coupled with a CE system as an end-column amperometric detector for the separation of 
carbohydrates such as fructose, glucose, lactose, mannitol, and sucrose. The novel detection 
electrodes were able to successfully separate and detect a mixture of the five carbohydrates 
even when used for real samples such as milk and fruits after CE separation, demonstrating 
its selectivity and sensitivity. Specifically, the sensitivity and detection limit of the sensor 
were determined to be between 45.61 and 85.96 nA mM−1, and 0.87 and 1.64 μM, 
respectively (Figure 20D).
The graphene–nickel hybrid sensor was prepared via a single-step far-infrared-assisted 
reduction method, wherein GO and nickel(II) ions were reduced in a hydrazine-containing 
solution (Figure 20E and F).151 The graphene–nanoparticle hybrid structures were then 
loaded onto the surface of a magnetic electrode and used to detect the same carbohydrates 
including glucose, fructose, lactose, mannose, and sucrose. Using this system, the peak 
currents were found to be significantly stronger than those of Ni nanoparticles alone for the 
same reasons as described for the graphene–copper nanoparticle hybrids. However, in 
comparison to the graphene–Cu nanoparticle hybrid, the graphene–Ni nanoparticle hybrid 
was much easier to load on to the magnetic electrode due to the ferromagnetic properties of 
nickel and could be fabricated easily and at a low cost. The authors also observed that the 
graphene–Ni nanoparticle hybrid sensor had superior performance in comparison to the 
graphene–Cu nanoparticle hybrid sensor. In particular, this sensor exhibited a good linearity 
from 0.001 to 1 mM and a sensitivity of 42.15 nA mM−1. Moreover, the detection limit was 
estimated to be 474 nM, and the sensor exhibited good reproducibility (relative standard 
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deviation of 4.3% over nine measurements) as well as selectivity (current response to 0.1 
mM UA, DA, and AA was 5.7%, 7.2%, and 5.1% of the response to 1 mM glucose). 
Overall, the nickel-based hybrid sensor was superior to the copper-based sensor due to the 
fact that nickel exhibits a much stronger electrocatalytic activity toward the oxidation of 
carbohydrates in alkaline solutions.151 However, in both cases, the presence of graphene 
greatly enhanced the strength of the electrochemical signal when compared to either 
nanoparticles (e.g., copper or nickel) alone due to the high surface area and excellent 
electrical properties of graphene.
Finally, the concept of utilizing graphene–nanoparticle hybrid structures for the catalysis of 
electrochemical reactions has also been extended to the detection of hydrogen peroxide 
(H2O2) in living cells. For instance, Jiang and co-workers recently fabricated an 
electrochemical sensor that integrated graphene with AuNPs and poly(toluidine blue O) 
(PTBO) films (Figure 21).152 The rationale behind this choice of nanomaterial was based on 
the fact that AuNPs have an excellent catalytic ability for H2O2 and incorporation of AuNPs 
could improve the electron transfer between the analyte and electrode.153 On the other hand, 
PTBO provided the ideal matrix to enclose the AuNP–graphene hybrid structures. 
Specifically, a layer-by-layer approach was used to deposit AuNPs (80 nm) and PTBO film 
onto rGO. The resulting sensor was characterized by a H2O2 sensitivity of 24.52 μA mM−1 
cm−2 and a LOD of 0.2 μM. Furthermore, exposure to DA, AA, UA, and glucose yielded 
little current response and did not affect the sensor’s response to H2O2. As a potential 
explanation for these observations, the authors noted that the low applied potential (−0.3 V) 
as well as the design of the electrode helped endow the sensor with its high sensitivity and 
selectivity. To detect H2O2 in living cells, the cells were separated from the culture medium 
and resuspended in deoxygenated PBS. H2O2 generation was then stimulated by the addition 
of AA resulting in the efflux of H2O2 from cells, which was detected and quantified. In 
particular, H2O2 levels were determined for K562 (human leukemia), PC12 (rat adrenal 
medulla pheochromocytoma), HepG2 (human hepatocarcinoma), L02 (human embryo liver), 
and RSC (rat synovial) cells (Figure 21B). The results indicated that a higher efflux of H2O2 
occurred in tumor cells versus normal cells suggesting that there was a decline in the 
enzymatic ROS-scavenging mechanisms in tumor cells, as AA should have induced equal 
production and distribution of H2O2 in tumor and normal cells.
3.3. Optical Sensors
The deoxidation of GO to rGO results in the formation of a material that is not only 
electrically conductive but also optically transparent with a transparency of ~97.7% and a 
transmittance that linearly decreases with the number of layers.154 As such, besides their 
excellent electronic and electrochemical properties, graphene–nanoparticle hybrid materials 
that utilize graphene or rGO possess a number of advantageous optoelectronic properties as 
well, which can be utilized for optical sensing applications. In particular, optical sensors that 
incorporate graphene nanomaterials fall into two categories: (1) fluorescence-based and (2) 
SERS-based biosensors. In the case of fluorescence-based biosensors, GO and rGO have the 
unique property in that not only are they fluorescent over a broad range of wavelengths (e.g., 
visible to NIR range with their maximum intensity being located between 500 and 800 
nm)155 but they also have the ability to quench fluorescent molecules such as dyes and 
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fluorescent nanomaterials (QDs and upconversion nanoparticles [UCNPs]).156 As such, 
graphene–nanopaticle composites composed of fluorescent nanomaterials are immensely 
useful for the development of fluorescence resonance energy transfer (FRET)-based and 
nanometal surface energy transfer (NSET)-based biosensors, which can enable the 
quantitative analysis of molecular dynamics in living cells on the single cell level. On the 
other hand, graphene exhibits remarkable Raman scattering properties, which are related to 
its unique electron and phonon structure.157 This Raman scattering can be greatly enhanced 
by the inclusion of metal nanoparticles (e.g., AuNPs and AgNPs) as graphene–metal 
nanoparticle hybrids, resulting in exceptional SERS effects, which can be used to detect the 
presence of individual biomolecules.29b In the following subsections, we will describe the 
use of graphene–nanoparticle hybrid materials for optical sensing. In particular, we will 
focus on fluorescence-based and SERS-based biosensors.
3.3.1. Fluorescence-Based Sensors—FRET is a type of fluorescence phenomenon 
that can occur when two fluorescent molecules are sufficiently close to one another 
(typically 1–10 nm). In this phenomenon, the energy from one fluorophore flows to the other 
via a nonradiative transfer.158 Specifically, the first fluorophore, which is typically denoted 
as the “donor”, is initially excited by an external optical source. Instead of emitting a photon, 
the excited donor transfers energy to the neighboring fluorophore, which is termed the 
“acceptor”. This leads to (1) the emission of fluorescence at the acceptor’s characteristic 
wavelength and also (2) quenching of the donor fluorophore. Because of the fact that the 
intensity of FRET depends strongly on the distance between the two fluorophores and their 
relative orientation as a donor or acceptor, FRET can be used to study, detect, and quantify 
interactions that occur between two molecules. The donor and acceptor fluorophores can be 
brought together in many different configurations. For instance, one fluorophore can be 
attached to a substrate while the other is attached to its binding site, and once the analyte of 
interest binds, FRET would be initiated. Alternatively, two fluorophores can be attached to a 
single protein and FRET can be initiated if and when the protein alters its conformation. 
Finally, the fluorophores can be linked to induce FRET, and once the linkage is cleaved (e.g., 
by an enzyme), FRET will cease to occur. As such, FRET is an excellent biosensing 
technique that can be superior to other optical detection methods in terms of its selectivity 
and sensitivity.159 Moreover, FRET sensing is a nondestructive method that can be used to 
detect molecular interactions within single living cells.
Graphene and GO sheets were recently found to exhibit super quenching capabilities as 
energy acceptors for fluorescent dyes, whose efficiency is estimated to reach up to 30 nm, 
thereby providing greater flexibility for the construction of fluorescence sensors based on 
FRET. Similar to the quenching effect seen with AuNPs, the mechanism underlying the 
superquenching effect of graphene and GO follows the NSET mechanism. Therefore, due to 
the superior-quenching ability of graphene (e.g., the rate of this long-range resonance energy 
transfer depends on d−4, where d is the distance, whereas traditional FRET depends on d−6),
160
 it can be coupled with other fluorophores such as fluorescent nanoparticles (e.g., QDs 
and UCNPs) for use as FRET-based biosensors with enhanced capabilities.
In recent years, the use of anti-Stokes fluorophores such as UCNPs, which can be excited in 
the NIR, have successfully circumvented issues with autofluorescence and the scattering of 
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light, which typically arise when utilizing FRET in biological tissue. In particular, rare earth-
containing UCNPs are able to emit high-energy photons under NIR excitation, which results 
from a nonlinear optical upconversion process, where the sequential absorption of two or 
more photons results in the emission of a single photon at a shorter wavelength.161 As such, 
the use of UCNPs has made it possible to utilize FRET-based sensors directly on biological 
samples, wherein the use of graphene–UCNP hybrids has even greater advantages due to the 
superquenching properties of graphene, which greatly enhance the range of achievable 
FRET. As an example, Zhang et al. utilized graphene–UCNP hybrids for glucose sensing.162 
In their system, they synthesized 50 nm water-soluble NaYF4:Yb,Er UCNPs modified with 
poly(acrylic acid), which were then conjugated with concanavalin A (conA) via EDC 
coupling. On the other hand, the GO sheets were functionalized with chitosan, which also 
occurred via EDC coupling. In terms of the underlying mechanism, conA and chitosan were 
able to form tight bonds, which brought the UCNPs and GO into appropriate proximity to 
induce FRET (81% degree of quenching). However, in the presence of glucose, the FRET 
process was inhibited because of competition between glucose and chitosan for ConA. By 
utilizing this system, Zhang and coworkers were able to achieve a LOD of 0.025 μM even in 
the presence of serum. Specifically, the FRET process in the presence of serum was found to 
be nearly the same (with minor differences in the slope), suggesting the selectivity of the 
sensor.
Similarly, Wu et al. utilized BaYF5:Yb,Er and BaYF5:Yb,Tm UCNPs that were 
functionalized with aptamers against ochratoxin A (OTA) and fumonisin B1 (FB1), 
respectively.156c In particular, OTA and FB1 are mycotoxins, which are a group of chemical 
substances that are produced by some fungal species and can cause illness or even death. As 
such, strong π–π stacking between the aptamers and the sp2 atoms of GO could be used to 
initiate FRET, and, in the presence of OTA and FB1, strong binding of the aptamers to the 
analytes resulted in the release of the UCNPs, thereby decreasing FRET (Figure 22). By 
utilizing this mechanism, the authors achieved a linear range from 0.05 to 100 ng mL−1 for 
OTA and 0.1 to 500 ng mL−1 for FB1 and a detection limit of 0.02 and 0.1 ng mL−1 for OTA 
and FB1, respectively. In terms of selectivity, aflatoxins B1, B2, G1, and G2, fumonisin B2, 
and zearalenone, which are all homologues of other mycotoxins found in foods, were 
evaluated. It was determined that only FB1 and OTA could induce a dramatic fluorescence 
enhancement at their corresponding peaks, whereas the other analogues could not.
QDs also exhibit a number of advantageous properties that make it an attractive 
nanomaterial for the formation of graphene–nanoparticle hybrids for FRET-based 
biosensors. In particular, QDs are inorganic and, as such, exhibit good resistance to 
photobleaching. Moreover, they exhibit a narrow emission band, broad absorption spectra, 
and have a size-tunable emission.69 Dong et al. gave the first report of efficient FRET 
between QDs and GO for biosensing applications.156b Specifically, CdTe QDs that were 
conjugated with either a molecular beacon (MB), which is a single-stranded oligonucleotide 
hybridization probe with a stem-and-loop structure in which the loop contains a probe 
sequence that is complementary to a target sequence and the annealing of self-
complementary 5′ and 3′ ends forms a stem, or aptamer, were used to detect DNA 
concentration and sequence (e.g., via MB) as well as proteins such as thrombin (e.g., via 
aptamer) (Figure 23). By utilizing this structure, a linear range was obtained from 50 to 1500 
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nM and a LOD of 0.5 and 50 nM was achieved for thrombin and ssDNA, respectively, which 
is highly sensitive and selective when compared to the other fluorescence or FRET-based 
methods (Figure 23B).156b Specifically, the MB-QD probe was able to differentiate between 
the perfectly complementary target, single-base mismatched strand (signal was 40% of the 
perfectly complementary target), and three-base mismatched strand (signal was 15% of that 
perfectly complementary target). Moreover, the quenching efficiency was much higher for 
MB-QDs than the typical efficiency seen in MB-based detection, which helped improve the 
achievable sensitivity and dynamic range.
Similarly, Li et al. reported a novel “turn-on” fluorescent sensor that utilized a QD/aptamer-
GO hybrid to detect lead(II) ions.163 However, it should be noted that this concept could also 
be readily applied to the detection of biomolecules. Specifically, hybrids were formed 
between the aptamer-functionalized CdSe/ZnS QDs, which had a characteristic fluorescence 
emission at 569 nm, and GO via π–π stacking. In the presence of Pb2+, these complexes 
were capable of changing their structural conformation from a one-dimensional structure to 
a G-quadruplex/Pb2+ complex, leading to the detachment of the QD/aptamer complex from 
the surface of GO. This detachment then allowed for monitoring using fluorescence 
microscopy. In this way, the authors achieved a linear response range of 0.1–10 nM and a 
LOD of 90 pM (0.019 parts per billion) with the authors attributing this high sensitivity to 
the super quenching capabilities of GO, the significant difference in the affinity of the 
aptamer toward Pb2+ and GO, as well as the low background signal due to the “turn-on” 
configuration. Moreover, when comparing the performance of this sensor to previous reports 
utilizing fluorescence, colorimetric, and electrochemical devices, this hybrid sensor 
exhibited a LOD that was 1–3 orders of magnitude better.164 Finally, the sensor exhibited 
excellent selectivity toward Pb2+ wherein exposure to other metal ions such as Ag+, Ca2+, 
Cd3+, CO2+, Cu2+, Fe3+, Hg2+, K+, and Ni2+ did not induce any evident change in 
fluorescence.
Last, researchers have combined GO with noble metal nanoparticles to induce a double-
quenching effect that resulted in an increase in the achievable signal-to-noise ratio and 
thereby amplified the achievable sensitivity. For example, Qu et al. reported a DNA-silver 
nanocluster–GO nanohybrid material for the detection of multiple nucleic acid targets 
(Figure 24).165 In this biosensor, Ag nanoclusters were functionalized with a ssDNA 
reporter that had a cytosine-rich DNA sequence (C12) resulting in highly fluorescent Ag 
nanoclusters. These DNA–silver nanoclusters were then added to a solution of GO resulting 
in complex formation via π–π stacking and fluorescence quenching. Once the target 
sequence was introduced, the high binding affinity between the reporter DNA and the target 
sequence resulted in the release of the DNA–silver nanocluster and induced strong 
fluorescence that correlated with the concentration of target sequence DNA present. Using 
this mechanism, the authors could detect multiple target nucleic acids with a high sensitivity 
(LOD: 1 nM), which was attributed to the high achievable signal-to-noise ratio resulting 
from the high quenching efficiency of GO. In terms of the selectivity, the sensor could 
discriminate between perfectly complementary target, one-base mismatched target (88.4% 
of the perfect target’s signal), two-based mismatched target (67.4% of the perfect target’s 
signal), and noncomplementary target (22% of the perfect target’s signal). Chen and co-
workers also reported a similar detection platform that utilized AuNP-functionalized 
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graphene for the detection of lead ions. This sensor was found to function in the 
concentration range of 50–1000 nM and had a LOD of 10 nM.166
3.3.2. SERS-Based Sensors—SERS is a surface-sensitive technique that allows for the 
enhancement of Raman scattering by molecules attached to or in close proximity of metal 
nanostructures and is one of the best techniques available for molecular analysis with 
sensitivities that can reach as low as the detection of single molecules.167 In particular, 
SERS is a phenomenon that can amplify normally weak Raman signals by many orders of 
magnitude and occurs due to a combination of chemical enhancement, which is mainly 
related to the charge transfer that occurs between the metal nanostructure and the analyte 
molecules, with electromagnetic enhancement (e.g., induced by the surface electron 
oscillation in the structure).168 As such, SERS-based sensors have been used in a variety of 
detection applications ranging from physics and engineering to biology and medicine.169
To achieve high electric field intensities and to acquire significant enhancement in 
achievable sensitivities, it has become a common practice to pattern nanoparticles/nano-
structures composed of noble metals (e.g., Cu, Ag, or Au) on substrates (e.g., silicon wafer). 
Enhancement is primarily caused by amplified, light-induced electric fields that exist on the 
surface of the patterned metallic nanoparticles. Specifically, when the incident light is in 
resonance with the oscillations of conducting electrons in a metallic nanoparticle, all of the 
electrons are collectively driven to oscillate in an optical phenomenon known as localized 
surface plasmon resonance (LSPR).170 This LSPR phenomenon is then responsible for the 
strong scattering and absorption of light that is typically observed when utilizing metallic 
nanoparticles. This phenomenon is also responsible for the generation of enhanced E-fields 
on the surface of the nanoparticles at sites that are known as “hotspots”. Consequently, 
molecules within these hotspots experience enormous enhancement in their Raman cross-
section, thereby potentially allowing for the detection of single molecules.171
Interestingly, recent studies have found that graphene and GO also have the ability to 
enhance Raman signals via a chemical enhancement mechanism, which is independent of 
the Raman enhancement caused by noble metal nanoparticles.172 In particular, it has been 
shown that mechanically exfoliated graphene sheets can induce Raman enhancement with a 
maximal enhancement of 17-fold, due to electron transfer that occurs between graphene and 
the molecules adsorbed on its surface.173 Therefore, by using graphene or GO, which 
possesses numerous active oxygen sites that can enhance graphene–metal nanoparticle/
molecule binding, it can be expected that the combination of graphene materials and metal 
nanoparticles would act synergistically to further enhance SERS when compared to using 
either graphene or metal nanoparticles alone (e.g., dual-enhancement of Raman signals by 
hybrid materials via chemical and electromagnetic enhancement). Using this strategy, 
graphene–nanoparticle hybrid materials have been developed to successfully detect a variety 
of biomolecules. For example, He et al. developed a SERS-active substrate based on AuNP 
decorated CVD graphene and used it for the multiplexed detection of DNA.174 Specifically, 
large films of graphene (120 μm × 120 μm) were generated and AuNPs (20 to 50 nm) were 
formed spontaneously on the film by immersion in HAuCl4 wherein direct redox occurred 
between the metal ions and the graphene sheets. To detect DNA, the AuNPs were 
functionalized with thiolated DNA probes (up to two different DNA probes were used). 
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Following the exposure of the device to the target DNA and the addition of a reporter DNA 
labeled with Cy3, which resulted in the formation of a sandwich composed of capture/target/
reporter DNA, multiplex detection of DNA was achieved with a LOD of 10 pM (Figure 25). 
On the other hand, addition of uncomplementary DNA at the same concentration resulted in 
little to no signal. Moreover, it was shown that the graphene–AuNP substrate enhanced 
Raman signals significantly more than SiO2/Si and graphene–SiO2/Si substrates alone due to 
the coupled surface plasmon resonance absorption of AuNPs on the graphene film.
A number of studies have also utilized graphene–AgNP hybrids for SERS biosensing. For 
example, Ren et al. developed a GO–AgNP hybrid structure that could function as a Raman-
enhancing material to detect folic acid (FA) in water, as FA has been reported to play a 
significant role in diseases such as cancer, heart attack, and mental degeneration.175 In 
particular, GO–AgNP hybrids were obtained via self-assembly, wherein GO sheets were first 
functionalized with poly-(diallyldimethylammonium chloride) (PDDA). Because of the 
cationic nature of PDDA, the GO–AgNP hybrids could capture negatively charged FA 
molecules resulting in a sensor that exhibited a LOD of 9 nM and a linear response between 
9 and 180 nM even when mixed with serum proteins. Importantly, despite depending on 
electrostatic interaction as its sensing mechanism, the unique SERS spectra of FA could be 
distinguished from serum proteins. Moreover, it was actually found that the SERS spectra of 
serum were quite similar to that in water with comparable intensities and the addition of a 
few peaks. As with the report by He et al., the authors reported that the Raman signals of FA 
were much higher on GO–AgNP hybrid structures than on normal AgNPs due to the 
presence of strong electrostatic interactions. GO–AgNP hybrids have also been applied to 
monitor prohibited colorants in food,176 wherein the GO–AgNP hybrids were used to detect 
mixtures of up to four prohibited red (e.g., allura red, ponceau, amaranth, and erythrosine) or 
yellow (e.g., lemon yellow, sunset yellow, orange II, and chrysoidin) colorants by their 
characteristic peaks with a LOD of 10−5 M. Similarly, GO–AgNP hybrids that were 
prepared via a one-pot method, where tannic acid, a water-soluble, phenolic hydroxyl-rich 
compound, was used as the reducing agent, were used to detect H2O2 and glucose without 
the need for glucose oxidase at a LOD of 7 and 100 μM, respectively.177 Finally, Long et al. 
recently reported a disposable biosensor composed of a GO–AgNP composite on a screen-
printed electrode that was capable of monitoring different polar antibiotics (e.g., MT, AT, 6-
AA, and PG) in situ with a LOD of 1 nM (Figure 26).178 In this case, SERS was combined 
with electrophoretic preconcentration (EP), a process that draws charged analytes toward 
SERS substrates through electrostatic force, to increase the concentration of analyte in the 
enhancement regions of the graphene–nanoparticle hybrid device. By combining SERS with 
EP, the antibiotics could be selectively adsorbed on the GO–AgNP sensor by controlling the 
applied potential in the EP process, and the SERS spectra of a mixture of different analytes 
could be obtained and distinguished within a 10 min time frame without any preseparation.
Last, GO nanocomposites have also been applied for live cell-based SERS applications. Liu 
et al. recently reported a graphene–AuNP hybrid for SERS in which gold nanostructures 
were grown intracellularly.179 Specifically, this process was assisted by 
polyvinylpyrrolidone (PVP)-functionalized GO, which acted as an activator for AuNP 
(IGAuNPs) biosynthesis. In terms of its mechanism of action, PVP is a nonionic, water-
soluble, and nontoxic polymer surfactant that can be employed as a stabilizing and 
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coordinating agent for the synthesis of metal nanoparticles.180 As such, by delivering trace 
amounts of PVP into the cell via functionalization of GO, not only did PVP serve as a 
biocompatible stabilizer for GO, but it also provided a template to coordinate the reduction 
of gold ions via intracellular redox systems, thereby forming 100 nm graphene–AuNP 
hybrids termed PVP/GO/IGAuNPs (Figure 27A and B).179 The distribution of PVP/GO/
IGAuNs in the cells (A549, 4T1, HeLa cells) then allowed for the sensitive monitoring of 
intracellular chemical compositions including proteins, nucleic acids, lipids, and 
carbohydrates within 15 h. Moreover, the hybrids could be used to monitor the intracellular 
composition of the different cellular compartments including the cytoplasm, nucleoplasm, 
and even the nucleus using SERS (Figure 27C and D). Specifically, a comparison between 
the SERS spectra of GO/PVP/IGAuNPs and IGAuNPs alone showed that the hybrid 
structure results in a 5 times larger Raman enhancement, possibly due to the formation of 
IGAuNP aggregates on GO. As such, the authors stated that the device showed potential for 
cancer detection. Similarly, Liu and co-workers also reported GO–AgNPs, which enabled 
very rapid cancer cell probing and imaging with a detection time of 0.06 s per pixel.181 In 
this case, the GO–AgNP composites were synthesized via an in situ reduction process that 
also used PVP as the reductant and stabilizer.182 For their studies, Raman images of HeLa 
cells were taken after 8 h of incubation with 1 ug mL−1 GO or GO–AgNPs. The Raman 
signals of GO were almost undetectable in the cells incubated with GO alone. However, the 
hybrids showed remarkable enhancement (~48.4-fold enhancement). Finally, selective 
labeling of cancer cells could be achieved by covalently functionalizing the GO–AgNPs with 
FA.
4. CELLULAR INTERACTIONS WITH GRAPHENE–NANOPARTICLE HYBRID 
MATERIALS
Nanoparticles possess a number of distinctive properties that make them useful for 
applications in cellular biology. For instance, their small size (e.g., 5–100 nm diameter) 
allows for easy delivery into cells by crossing the plasma membrane.183 Moreover, the 
surface chemistry can be adjusted such that the nanoparticles selectively interact with 
individual biomolecules found either on the cell membrane or within the cytoplasm, specific 
normal/diseased tissues, or bodily fluids (e.g., blood, interstitial fluids, etc.). As such, 
numerous studies have reported the synthesis of nanoparticles with different inorganic and 
organic compositions, including noble metal, magnetic, polymeric, semiconducting, 
upconversion, and silica nanoparticles.184 The ability to tune the properties of these 
nanoparticles has permitted scientists and clinicians to effectively utilize nanoparticles for 
various cellular applications including bioimaging, drug delivery, and tissue engineering.
180,185
 At the same time, graphene-based nanomaterials exhibit unique physicochemical, 
thermal, mechanical, and optical properties, which have also made them attractive for 
biomedical applications.186 Therefore, in the last five years, researchers have successfully 
combined the intrinsic properties of nanoparticles and graphene-based nanomaterials within 
single graphene–nanoparticle hybrid platforms to make remarkable advances in a variety of 
cellular applications. In this section, we will highlight the recent cellular applications of 
graphene–nanoparticle hybrid structures, mainly focusing on the areas of bioimaging, 
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photothermal therapies (PTTs), drug/gene delivery, multifunctional therapies, and stem cell/
tissue engineering.
4.1. Bioimaging
Understanding complex biological systems entails learning how individual components 
within living cells form, how they are organized, how they interact, and how they assemble 
to provide structure and function. The need to visualize and, in turn, assess these different 
processes within living cells, tissues, and whole organisms has undoubtedly necessitated the 
development of sophisticated bioimaging techniques. In addition to acquiring a better 
understanding of how normal biological processes occur, bioimaging can even enable the 
monitoring of abnormal processes caused by cancer and disease, thus underscoring its 
importance in medicine. At the most basic level, bioimaging encompasses techniques to 
visualize biological processes in living cells or animals using specialized imaging probes. 
However, with clinical applications hampered by poor sensitivity, specificity, and targeting, 
there is a constant need to develop more advanced bioimaging probes and imaging 
modalities.187 To this end, graphene–nanoparticle hybrid materials have shown great 
promise as the next generation of imaging probes. We will briefly review the three main 
imaging modalities in which these hybrid nanostructures have made the most impact, 
specifically (1) MRI, (2) Raman spectroscopy, and (3) fluorescence imaging.
4.1.1. Magnetic Resonance Imaging (MRI)—When it comes to investigating tissues 
within the body and monitoring the progression of cancer or disease, MRI is the most widely 
used medical imaging technique. MRI takes advantage of tissue contrast that is generated 
from nuclear magnetic resonance (NMR) signals received from hydrogen nuclei located in 
different physiological environments/tissues throughout an organism. Among other factors, 
the spin–lattice longitudinal relaxation time (T1) and the spin–spin transverse relaxation time 
(T2) are crucial in determining the MRI signal intensity, wherein the magnitude of the MRI 
signal increases with decreasing relaxation times. However, the inherent difference in the 
relaxation times between two given biological tissues tends to be insufficient to obtain a 
detectable signal. As a result, contrast agents bearing paramagnetic or superparamagnetic 
properties (e.g., from metals belonging to lanthanide and transition metal series) were 
developed to achieve enhanced contrast.
MRI contrast agents work by reducing the T1 and/or T2 relaxation times of the protons in the 
vicinity of the metal-containing agent, in turn making areas in the image brighter or darker 
for better detection. Initially, GdIII was established as one of the best contrast agents due its 
large magnetic moment, but it has issues with uptake in extravascular space and toxicity in 
its ionic form.188 In recent years, MNPs, such as Fe2O3 and Fe3O4, have proven to be 
excellent MRI contrast agents, offering sufficient sensitivity for T2-weighted imaging.189 
Moreover, the formation of aggregates of MNPs has been reported to increase relaxivity 
rates (r2) and, in turn, improve MRI contrast.190 However, the uncontrolled aggregation of 
iron oxide NPs (IONPs) can cause precipitation of the NPs and thus reduce the time of 
circulation in the blood due to reticuloendothelial clearance.191 In this regard, graphene-
based nanomaterials were initially employed to serve as a scaffold with which to anchor 
IONPs, wherein IONP clustering on graphene sheets would enhance MRI contrast and the 
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chemical functionalities of the graphene sheets would improve the physiological stability of 
the aggregated MNPs. Early work in this area focused on developing efficient methodologies 
to prepare these graphene–MNP composites.192 For example, Cong et al. were among the 
first to report the synthesis and MRI imaging capabilities of rGO sheets decorated with 
monodisperse Fe3O4 NPs.193 In this case, the composites were prepared using a simple in 
situ method, wherein rGO sheets were reacted with an iron precursor, iron(III) 
acetylacetoante (Fe(acac)3). Using TEM, it was then determined that all of the MNPs were 
coated on the rGO sheets with no aggregated or free particles. Moreover, by adjusting the 
initial weight ratio of Fe(acac)3:rGO sheets, the coverage density of the MNPs and, in turn, 
the magnetic properties of the composites were finely tuned. For instance, saturation 
magnetization values of 19.6, 51.7, and 64.8 emu g−1 were achieved with initial weight 
ratios of 1:1, 2:1, and 4:1, respectively. While these composites were only shown to provide 
contrast in T2-weighted MR imaging (performed in 0.5% agarose gels), in vitro cellular 
imaging using GO–MNP composites as contrast agents was later demonstrated by Chen et 
al. using composites of aminodextran-coated Fe3O4 nanoparticles and GO sheets.194 The T2 
relaxivity of the GO–Fe3O4 composites (76 Fe mM−1 s−1) was found to be higher than that 
of Fe3O4 nanoparticles (21 Fe mM−1 s−1), indicating that enhanced MRI intensities can be 
achieved due to the formation of hybrid structures wherein the Fe3O4 NPs formed 
aggregates on the GO sheets. In addition, the GO–Fe3O4 composites remained stable under 
physiological conditions, and delivery to HeLa cells allowed for the detection of as few as 
1000 cells mL−1 (Fe concentration of 20 μg mL−1). However, there was a significant drop in 
the MR relaxation rate of the Fe3O4–GO composites to 31 mM−1 s−1 upon incubation with/
delivery into cells. While this is to be expected, possibly due to the slower rate of diffusion 
for water inside the cell, when the composites are confined in the endosomes, a further 
enhancement of T2 relaxivity would be desirable to apply these hybrids for in vivo MRI 
cellular labeling.
To this end, recent studies have demonstrated a method to further enhance the T2 relaxivity 
by assembling nanoparticles possessing varying morphologies and composition onto GO 
sheets. One such study by Chen et al. reported the in situ growth of β-FeOOH nanorods 
(longitudinal length of 20 nm and transverse diameter of 3 nm) onto polyethyelene glycol-
coated (PEGylated) GO sheets.195 These GO-PEG-β-FeOOH composites exhibited an 
ultrahigh transverse relaxivity (r2) of 303.81 mM−1 s−1, which was 60 times higher than 
those achieved by previous β-FeOOH-based MRI contrast agents (Figure 28).196 These 
nanocomposites produced an exceptional enhancement in T2-weighted MR imaging for in 
vitro HeLa cell cultures, as well as for in vivo studies in mice. Specifically, a significant 
darkening of the liver was observed in the T2-weighted images about 2–4 h after intravenous 
administration of the nanocomposites, which was further confirmed with TEM images that 
showed uptake of the composites into the mouse liver. Overall, these studies provide 
remarkable evidence for the benefits of combining MNPs with GO sheets to enhance the 
capabilities of MRI contrast agents via the controlled formation of MNP aggregates on the 
graphene sheets.
4.1.2. Raman Spectroscopy—Raman spectroscopy is an alternative mode of imaging 
that relies on the intrinsic structure and properties of graphene-based nanomaterials. Raman 
Yin et al. Page 34
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
spectroscopy is widely used to characterize GO due to its characteristic fingerprint in the 
Raman spectra (D band at ~1350 cm−1 and G band at ~1600 cm−1). However, the 
introduction of noble metals, such as AuNPs and AgNPs, onto GO sheets has been found to 
promote surface-enhanced Raman scattering (SERS), which can be used to improve the 
Raman intensity and sensitivity of GO considerably.44b Resultantly, a number of studies 
have exploited this feature to utilize GO–noble metal composites as imaging probes in 
biological cells. For example, employing a traditional in situ synthetic approach as seen with 
MNPs, 20 nm AuNPs were formed on GO sheets via the reduction of AuCl4− with citrate to 
obtain GO–AuNP hybrids (Figure 29A).197 A 4-fold enhancement of the Raman spectra was 
observed for the GO–AuNP hybrids when compared to the original GO under the same test 
conditions, due to the surface enhancement effect of the AuNPs. Furthermore, when Raman 
imaging was performed following delivery of the GO–AuNP hybrids into HeLa 229 cells, it 
was observed that cells incubated with the GO–AuNP hybrids exhibited significantly 
enhanced Raman signals when compared to control cells incubated with only GO and only 
AuNPs (Figure 29B–I). Finally, rapid Raman imaging and high-resolution Raman images 
were acquired using a low laser power (3.5 mW) and short acquisition time (1 s). In terms of 
the mechanism of uptake, a simple study suggested that the GO–AuNP hybrids were 
internalized by an energy-dependent process such as endocytosis. These findings were 
further supported by a more detailed study performed by Huang et al., wherein SERS was 
used to demonstrate that internalization occurred through the clathrin-mediated energy-
dependent endocytosis route.198
In contrast to intracellular delivery, these hybrids can also be used as highly sensitive SERS 
probes to achieve targeted labeling of the cellular surface membrane. In one such study, GO–
AgNP composites were synthesized using an in situ reduction method for HeLa cell 
labeling.181 By varying the weight ratio between AgNO3 and GO, an optimal Raman 
enhancement was found with a ratio of 192. The GO–AgNPs were initially delivered 
without any modifications, resulting in the distribution of the hybrids almost exclusively in 
the cytoplasm. However, the authors also demonstrated targeted cellular delivery by 
covalently binding a FA molecule to GO hybrid structure via amide bond formation. In 
particular, FA is known to target the folate receptor (FR), which is overexpressed in the vast 
majority of cancers (e.g., epithelial, ovarian, breast, lung, and brain tumors) while having 
limited expression in healthy tissues and organs.199 As such, it is suitable for HeLa cell 
targeting.200 After incubating the FA-GO-AgNPs with FR-positive cells (HeLa) and FR-
negative cells (A549), the intensities of Raman signals acquired from HeLa cell were 2 
orders of magnitude higher than that of A549 cells. Moreover, extensive accumulation of the 
hybrids was found on the plasma membrane of the FR-positive HeLa cells after 4 h, with 
moderate signals found in the cytoplasm.
4.1.3. Fluorescence Imaging—Fluorescence-based techniques are widely used in the 
life sciences for imaging and diagnostics. However, fluorescence-based detection methods 
tend to have several limitations, including photobleaching, degradation of the chemical dye 
compound, and background autofluorescence from cells or tissues.201 Nevertheless, a 
number of studies employing GO–nanoparticle hybrids for fluorescence imaging have been 
conducted, which address several of these limitations. Sreejith et al. fabricated a GO-
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wrapped mesoporous silica nanoparticle (MSNP) for the encapsulation of squaraine dyes, a 
class of zwitterionic dye that exhibits photophysical properties in the NIR region.202 While 
suitable for numerous bioapplications, squaraine dyes tend to lose their photophysical 
properties in aqueous medium due to aggregation and nucleophilic attack of the squaryl 
rings. Therefore, sequestering the dye in MSNPs and then further capping the pores with GO 
ensured the minimal loss of the dye from leakage, improved the stability of the dye by 
preventing nucleophilic attack from thiol-containing molecules generally found in the 
cytoplasm (e.g., cysteine, glutathione), and allowed for fluorescence imaging in cancer cells.
While dyes are conventionally used for fluorescence imaging, semiconductor QDs overcome 
many of the limitations of traditional dyes and allow for tunable emissions.203 Recently, 
hybrid nanocomposites of zinc-doped AgInS (AIZS) QDs and GO were synthesized for in 
vitro imaging of NIH/3T3 cells.204 Freshly prepared hydrophobic AIZS nanoparticles were 
assembled onto oleylamine-modified GO, followed by PEGylation of the nanocomposites to 
improve colloidal stability in aqueous medium (Figure 30A). In doing so, the authors 
reported that they could enhance the solubility and stability over AIZS nanoparticles alone. 
Specifically, the AIZS–GO nanocomposites dispersed well in water with no observable 
aggregation. Moreover, varying the doping amount of zinc in the AIZS nanoparticles 
allowed for the preparation of nanocomposites with green, yellow, orange, and red colors 
(Figure 30B). These nanocomposites possessed a diameter of about 130 nm under 
physiological conditions and exhibited no obvious cytotoxicity in NIH/3T3 cells (1 to 100 
ug mL−1). The nanocomposites also showed strong photoluminescence, wherein confocal 
imaging revealed that the nanocomposites accumulated in the cytoplasm around the nuclei 
(Figure 30C).
4.2. Photothermal Therapies
Temperature is an important factor that determines the viability and functionality of 
biological entities ranging from cells to entire organisms. While an increase in temperature 
above the normal body temperature (37 °C) is normally a sign of illness, the controlled 
increase in temperature of targeted tissues has been reported to have numerous therapeutic 
benefits in patients with cancer or disease.205 The clinically relevant temperature range for 
thermal treatments has been reported to be between 41 and 48 °C, a range that is referred to 
as hyperthermia.206 Moderate levels of hyperthermia appear to be adequate for inducing 
protein denaturation and aggregation, while reducing cellular resistance against orthogonal 
cancer treatments (e.g., chemotherapy, radiation, etc.). On the other hand, short thermal 
treatments above 48 °C for even several minutes (or long exposures in the clinically relevant 
range for several hours) can cause excessive necrosis and ablation, leading to severe and 
irreversible damage. As a result, the development of novel tools and techniques for 
controlled heating in localized areas has been a major focus for advancing thermal therapies. 
In regard to such thermal therapies, PTT has gained tremendous attention, wherein 
photoabsorbing agents generate heat upon exposure to optical energy. Among the various 
types of nanomaterials available for this purpose, graphene-based structures exhibit strong 
optical absorbance in the NIR range, which makes it an especially effective PTT agent. In 
addition, modification of the graphene surface to further incorporate inorganic nanoparticles 
allows for the generation of hybrid materials with a greater dynamic range of heating, 
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enhanced temperature control, and the incorporation of imaging modalities as well as other 
functionalities.
In one study, rGO–IONP composites were applied for in vivo PTT in a 4T1 murine breast 
tumor mouse model.207 In particular, the nanocomposite was prepared by the hydrothermal 
reaction of GO and iron chloride hexahydrate, resulting in the distribution of IONPs (8–10 
nm) on the rGO surface.208 Further grafting with a PEG-based moiety imparted stability in 
physiological solutions, as well as a significant reduction in the mean hydrodynamic 
diameter from >200 to ~50 nm. The resulting rGO-IONP-PEG exhibited greater NIR 
absorbance than the as-made GO at the same GO concentration, underscoring the advantage 
of a graphene–nanoparticle hybrid for inducing photothermal effects. Intravenous injection 
of 125I labeled rGO-IONP-PEG in mice bearing 4T1 tumors revealed primary accumulation 
in the liver and spleen as expected (~12–15% injected dose [ID] g−1), in addition to passive 
accumulation in the tumor site (~5% ID g−1). In vivo photothermal studies were then 
conducted by intravenously injecting tumor-bearing mice with rGO-IONP-PEG and then 
irradiating the tumors after 48 h with 808 nm laser (0.5 W cm−2) for 5 min. The surface 
temperature of the tumors in nanocomposite injected mice increased to 48 °C after laser 
exposure, as compared to 39 °C in untreated mice after laser exposure. Moreover, the tumors 
were ablated after photo-irradiation without regrowth over 40 days, whereas the control 
groups showed rapid growth and eventually led to death within 20 days.
In another study, IONPs were replaced with Au plasmonic nanostructures to form GO–Au 
nanocomposites.209 Given that Au nanostructures absorb NIR light and convert the 
electronic oscillations at the particle surface to heat, the combination with GO was observed 
to enhance photothermal effects. In contrast to assembling nanoparticle structures on GO, 
Au nanoshells (AuNS) (150 nm in diameter) and Au nanorods (AuNR) (10 nm width, aspect 
ratio = 3.5) were coated with rGO (Figure 31A–D). The photothermal performance of the 
AuNS and AuNR with and without rGO was studied in the dry state and solution state under 
NIR illumination (808 nm, 3.0 W cm−2). In the dry state for both particle types, rGO coating 
resulted in an approximately 2.9-fold increase in the temperature after photoirradiation. The 
solution state showed a similar trend, with a temperature change of 42.3 ± 0.2 °C for rGO–
AuNS and 47.5 ± 0.2 °C for rGO–AuNR over 5 min, both of which were greater than the 
rGO and Au nanostructures alone (Figure 31E,F). To explain this enhancement, the authors 
suggested that the AuNS and AuNR could serve as both photothermal sources through 
nonradiative decay as well as local nanoantennae to enhance the optical energy absorption of 
graphene at select plasmon frequencies.210 Finally, it was reported that human umbilical 
vein endothelial cells (HUVECs) exposed to the nanocomposites showed an irradiation time-
dependent decrease in cell viability, wherein 1 min of irradiation led to a sharp decrease in 
cell viability for RGO–AuNS treated (to 23%) and RGO–AuNR treated (to 33%) conditions 
(Figure 31).
Further advancing upon these hybrid platforms, Shi et al. generated a dual-nanostructured 
composite by combining both IONPs and Au nanostructures on GO.211 In this case, a layer 
of Au nanostructures was first synthesized on GO–IONPs, and then the overall hybrid was 
functionalized with PEG (Figure 32A). These GO-IONP-Au-PEG nanocomposites allowed 
for efficient PTT as well as dual-modal MRI (magnetic IONPs) and X-ray computed 
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tomography (CT) imaging (X-ray absorbance from Au). In vitro studies in 4T1 breast cancer 
cells showed that almost all cancer cells were killed after incubation with the hybrids and 
exposure to an 808 nm laser (2 W cm−2 for 5 min). Mice bearing 4T1 tumors were then 
intratumorally injected with GO-IONP-Au-PEG to assess in vivo imaging and PTT. T2-
weighted MR and CT images showed a clear contrast in the tumor of the hybrid-injected 
mice. Tumor-bearing mice were then injected with either GO-PEG or GO-IONP-Au-PEG at 
the same dose of GO (50 ug mL−1), and subjected to an 808 nm laser at 0.75 W cm−2 for 5 
min as controls. IR thermal images revealed that the surface temperature of the tumors 
injected with the nanocomposites rapidly increased to about 55 °C within 5 min of laser 
irradiation (as compared to 45 °C for GO-PEG and 38 °C for PBS only) (Figure 32B). 
Measurements of the tumor volume after irradiation showed effective ablation in the 
nanocomposite condition, whereas other control conditions (saline and GO-PEG, with and 
without irradiation) showed a continuous increase in tumor volume.
Last, to monitor the increase in temperature and the progress of PTT, Hu et al. designed QD-
tagged reduced GO (QD–rGO) nanocomposites.212 In this case, highly fluorescent 
CdSe/ZnS core–shell QDs, capped with a surfactant (TOPO) and a self-assembled 
monolayer of 11- mercaptoundecanoic acid (MUA), were assembled on 260 nm small rGO 
(S-rGO) and 38 nm ultrasmall rGO (US-rGO). FA was further tethered to the composites to 
enhance uptake in FR-expressing cells. As compared to the QD–S-rGO composites, the QD–
US-rGO exhibited higher fluorescence for cell imaging as well as greater cellular uptake. 
Interestingly, increasing the time of exposure to an 808 nm laser (2 W cm−2) not only 
resulted in cellular death, but there was a simultaneous loss of QD fluorescence. The loss in 
fluorescence was speculated to be due to the degradation of the MUA coating under 
excessive heating, which in turn reduced the QD protection and led to oxidation. In this way, 
the QD–rGO composite provided orthogonal functionalities, in which the cell death 
occurred from the local heating of rGO and the progress of the PTT was monitored and 
quantitatively estimated by measuring the decrease in QD fluorescence intensity.
4.3. Delivery of Drugs and Genes
The delivery of small molecule drugs and biomacromolecules (e.g., proteins, peptides, 
genes) to specific tissues of interest has been a fundamental approach in medicine. As 
compared to the conventional method of oral administration or intravenous injection, 
significant effort has recently been dedicated to enhancing bioavailability, achieving targeted 
delivery, more effectively solubilizing drugs/biomolecules of interest, and protecting drugs/
biomolecules from enzymatic degradation.213 In this regard, nanomaterial-based delivery 
platforms have revolutionized drug delivery systems, providing benefits from both the 
effective delivery and the imaging standpoints.214 Since the discovery of graphene in 2004, 
there has been increasing interest in loading graphene-based nanomaterials for the delivery 
of drugs/genes due to graphene’s high specific surface area and unique modes of complex 
formation including π–π stacking, electrostatic interactions, and hydrophobic interactions.
186
 More recently, the well-controlled modification of graphene materials with nanoparticles 
to form graphene–nanoparticle hybrids has been applied to improve their utility for both in 
vitro cancer cell assays and in vivo chemotherapies. In particular, as with the other cellular 
applications mentioned so far, the formation of graphene–nanoparticle hybrids can prevent 
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aggregation and provide additional functionalities over graphene or nanoparticles alone. 
Additionally, graphene–nanoparticle hybrids can greatly improve the drug loading capacity 
over graphene materials alone due to increases in overall surface area. To this end, early 
work focused on optimizing synthetic procedures to achieve high drug loading of poorly 
soluble drugs while maintaining maximal potency. For example, Yang et al. formed a GO–
Fe3O4 hybrid to investigate the binding of the anticancer agent doxorubicin (DOX).215 The 
hybrids were prepared via chemical deposition, followed by conjugation of DOX via 
sonication and overnight stirring resulting in a drug loading capacity as high as 1.08 mg mg
−1
. Recent work with a hybrid containing IONPs, AuNPs, and GO further improved the 
DOX loading capacity to 6.05 mg mg−1, which is significantly higher than GO alone (2.35 
mg mg−1).216 While a range of drug loading capacities have been demonstrated, the 
maximum achievable loading is heavily dependent on the synthetic conditions employed to 
prepare the hybrids, the chemical composition of individual components (e.g., GO, RGO, 
Fe3O4, Au, etc.), and the structure/composition of the small molecule drug.
While attaining sufficient drug loading is a key criterion for achieving a therapeutic effect, 
the effective delivery of the hybrid nanocarrier into the desired cancer cell/tissue is equally 
important. In one study, gold nanocluster (GNC)–rGO nanocomposites were loaded with 
DOX to investigate the effect on hepatocarcinoma (HepG2) cells.217 Specifically, GNCs 
ranging between 2 and 3 nm in diameter were noncovalently attached onto the rGO surface 
resulting in GNC–rGO nanocomposites that were less toxic than GNCs alone (IC50 values: 
1.36 μg mL−1 for GNC–rGO versus 0.36 μg mL−1 for GNCs). Next, DOX was loaded onto 
the GNC–rGO nanocomposites at a 91% drug loading efficiency, where the concentration of 
DOX was 0.22 mg mL−1 and that of GNC–rGO was 1 mg mL−1. The authors found that the 
DOX-loaded GNC–rGO inhibited HepG2 cell growth more strongly than DOX and GNC–
rGO alone, which suggested that DOX was more effectively transported into the cell by the 
GNC–rGO nanocomposite than when used alone. Moreover, while DOX treatment alone led 
to DOX molecules resting on the cellular membrane, the DOX-loaded GNC–rGO allowed 
DOX to be well-distributed inside the cells, thus suggesting the importance of such a 
composite vehicle to enhance membrane permeability. In a similar study, NGO sheets were 
wrapped onto the surface of individual AuNPs and then noncovalently bound with DOX for 
delivery into HeLa cells (Figure 33A).218 This methodology generated Au@NGO 
composites with a hydrodynamic size of 133.5 nm in culture media, a size range that 
allowed for facile cellular delivery. The intrinsic SERS signal from the Au@NGO further 
allowed for Raman imaging, which confirmed the efficient delivery and distribution of the 
nanocomposites in the cytoplasm. Interestingly, sustained release of the drug was observed 
in the DOX-loaded Au@ NGO composite condition, wherein the red fluorescence (DOX) 
within the nucleus gradually increased over 48 h and became higher than that seen in the 
cytoplasm (Figure 33B). In contrast, treatment with an equivalent amount of DOX showed 
fast nuclear accumulation within only 2 h, with no further enhancement in fluorescence over 
time. Moreover, DOX-loaded Au@NGO induced a significant decrease in HeLa cell 
viability when compared to free DOX (Figure 33C). This work suggests that while treatment 
with free DOX led to a burst dosing profile, the Au@NGO composite allowed for sustained 
release within the cancer cells, showing promise for long-term therapeutic efficiency.
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Targeted delivery of therapeutic agents is also highly desirable because it can allow for 
higher bioavailability of the agent at its site of action, while reducing side effects.219 As 
compared to passive transfection into cancer cells, a number of studies have attempted to 
chemically or physically modify the drug-loaded hybrid nanocomposite to enhance cellular 
internalization. Fan et al. prepared a graphene-CNT-MNP (Fe3O4) nanocomposite to 
investigate the delivery of the anticancer drug 5-fluorouracil (5-FU) into HepG2 cells.220 
While the high specific surface area of graphene allowed for higher drug loading than 
graphene-based drug carriers alone and the IONPs imparted superparamagentic behavior to 
the nanocomposite, the incorporation of CNTs was found to enhance transportation of the 
graphene-CNT-Fe3O4 hybrid across the cell membrane. TEM images comparing magnetic 
CNT nanocomposites (CNT–Fe3O4) and magnetic graphene nanocomposites (graphene–
Fe3O4) showed distribution of the CNT–Fe3O4 nanocomposites in the cell cytoplasm but 
graphene–Fe3O4 only outside of the cell. The study further showed dose-dependent in vitro 
cell toxicity studies using the graphene-CNT-Fe3O4 for fluorouracil (5-FU) drug delivery, 
providing further evidence for improved cellular delivery. On the other hand, to achieve a 
more targeted drug delivery, Chen et al. designed a QD-graphene-based hybrid composite 
that was conjugated with the transferrin (Trf) ligand.221 Specifically, Trf ligands are known 
to bind with high affinity to Trf receptors, which are expressed on the plasma membrane of 
various types of cancer cells.222 DOX-graphene-QD-Trf (loading capacity 1.4 mg mg−1) was 
incubated in a Trf positive cell line (HeLa) and a Trf negative cell line (HEK293). The DOX-
graphene-QD-Trf exhibited increased toxicity to HeLa cells as compared to the HEK293 
cells, while the DOX-graphene-QD and DOX-graphene-QD-Trf showed a similar effect on 
HEK293 cell viability. This effect was attributed to the specific Trf receptor recognition, 
which suggested that the ligand-specific conjugation of the nanocomposites could 
selectively increase drug cytotoxicity. Moreover, the QDs (CdTe–CdS nanocrystal clusters) 
allowed for fluorescence imaging, thus providing the capability to track and monitor drug 
delivery.
In addition to targeted therapies, remotely triggerable drug delivery systems have become 
popular because they enable the user to adjust dosing regimens on-demand,223 based on a 
patient’s physiological response. In a recent study, He et al. describe a photocontrolled 
release system by incorporating a photoacid generator (PAG) into DOX-loaded, GO-capped 
MSNPs (Figure 34A,B).224 In particular, PAG can generate strong acid via illumination with 
UV or near-UV light.225 As such, by assembling GO as nanogates on the MSNPs with acid-
labile boroester linkers, the PAG was used to generate a locally high concentration of H+ 
upon illumination. This, in turn, induced the hydrolysis of the boroester linkers to open the 
pores (by releasing the GO cap) and release the loaded DOX. The nanocomposites were 
further conjugated with folate, which allowed for targeted delivery to cancer cells 
overexpressing FRs. Selective cell death from the DOX-loaded nanocomposites was 
indicated by the significant cell death of approximately 80% in HeLa cells (high expression 
of FRs), but a negligible change in cell viability of L02 cells (low expression of FRs) (Figure 
34C).
While the majority of studies on graphene-based nanocomposites for drug delivery 
applications have employed inorganic nanoparticles for complexation with GO, Wang et al. 
were among the first to demonstrate the use of a soft nanoparticle in this regard, by 
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adsorbing zwitterionic dioleoyl-sn-glycero-3-phosphocholine (DOPC) liposomes onto NGO.
226
 The rationale for using DOPC liposomes was to adsorb multiple molecules on the same 
surface with little intermolecular competition, thus allowing for highly effective drug 
loading and controlled release. The nanoscale heterogeneity of the GO surface proved to be 
ideal, wherein DOX was loaded using the well-established hydrophobic interactions that 
occurs with the basal aromatic surface. On the other hand, the DOPC liposomes were 
speculated to adsorb using hydrogen bonding and hydration forces with the peripheral 
carboxyl groups. As such, DOPC liposomes may be adsorbed on GO at different sites from 
DOX, thereby avoiding competition. Interestingly, the DOPC/NGO complex not only 
exhibited improved aqueous dispersion and colloidal stability, but also allowed for an 
increased loading capacity of DOX (~500%) as compared to loading on only GO (~300%), 
which indicated that the DOPC liposomes did not interfere with the drug loading. In 
addition, it was also found that while free DOPC liposomes were not internalized by HeLa 
cells, the DOPC/NGO complex had high colloidal stability and readily entered the cells. 
Finally, the DOPC liposomes were simultaneously loaded with a calcein dye and delivered 
to HeLa cells, which exhibited a decrease in cellular viability (due to DOX) and green 
fluorescence from calcein. As such, this new soft nanoparticle-based GO hybrid system 
exhibited the ability to codeliver molecules with opposite properties (e.g., DOX is cationic 
and hydrophobic while calcein is negatively charged and hydrophilic) using a single 
platform.
Last, while the delivery of small molecule drugs has been extensively explored using 
graphene–nanoparticle composites, there have been limited studies demonstrating their use 
for gene delivery. PEGylated, polyethylenimine (PEI)-grafted graphene/Au composites 
(PPGA) have recently been used for the delivery of small interfering RNA (siRNA) into 
human promyelocytic leukemia cells (HL-60).227 The polymer coatings served specific 
functions, wherein the cationic PEI was used to bind electrostatically with negative charged 
siRNA while the PEG promoted high water dispersibility and excellent blood compatibility. 
The PPGA composites showed biocompatibility for in vitro cultures when used at 
concentrations below 20 μg mL−1, as well as knockdown of Bcl-2 protein expression at a 
PPGA/siRNA mass ratio of 100:4. Moreover, because these composites also contained 
AuNPs, the photothermal effect of PPGA was demonstrated under NIR laser irradiation. 
Finally, Wang et al. developed a strategy to combine chemotherapy and gene therapy using a 
single chitosan magnetic–graphene (CMG) nanocomposite platform.228 The CMG 
nanocomposites were synthesized by the in situ growth of IONPs on the rGO surface, 
followed by the covalent binding of chitosan. Thereafter, DOX was physically adsorbed onto 
the CMG composites (via interaction with GO) and a green fluorescent protein (GFP) 
reporter DNA plasmid (via interaction with positively charged chitosan). These DOX-CMG-
GFP complexes (30 μg of DOX and 25 μg of GFP-pDNA per mouse) were administered 
intravenously to LLC1 tumor bearing mice, whereby the presence of DOX (red) and GFP 
(green) expression was observed in frozen mouse sections (Figure 35) after 24 and 48 h. 
Biodistribution studies further showed significant accumulation in the tumor site, with lower 
accumulation in the liver and spleen. Moreover, the MNPs in the CMG composites allowed 
for MR imaging.
Yin et al. Page 41
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
4.4. Multifunctional and Multimodal Approaches
Graphene–nanoparticle hybrid composites are robust and versatile platforms that can be 
used in numerous distinct biological applications as described above, including imaging, 
PTT, and drug/gene delivery. In particular, the ability to exploit the intrinsic properties of 
these hybrids to achieve a combined, multifunctional therapy has drawn immense attention. 
As an example, combining chemotherapeutic drugs and other molecules with hyperthermia 
has been a common approach to enhance therapeutic efficacy.229 Dai and co-workers 
initially demonstrated such an integrated methodology using ultrasmall iron–cobalt (FeCo) 
MNPs (~4 nm) coated with a single- or few-layer graphitic carbon shell (GC).230 The 
rationale for this platform was that the highly magnetic FeCo core (r2 = 185 mM−1 s−1) 
would provide a high saturation magnetization for MRI contrast, while the GC shell would 
enable DOX loading (via π–π stacking) as well as absorbance of NIR light for photothermal 
effects. The FeCo/GC nanocrystals showed a pH-dependent release, wherein the release of 
DOX from FeCo/GC was observed to be a slow, continuous process that was about 3 times 
greater at pH 5.5 than pH 7.4 after 8 days. Moreover, the FeCo/GC had a slower DOX 
release profile than single-walled CNTs (~1 nm diameter). This was possibly caused by the 
stronger interaction between DOX and the graphitic sidewall of the hybrids as well as the 
more planar surface of the GC used in this system, which resulted in higher drug loading and 
slower release. Thermal imaging of the FeCo/GC solution further showed a temperature 
increase of ~35 °C following only 10 min of NIR light exposure (808 nm, 0.3 W cm−2). In 
vitro studies with MCF-7 breast cancer cells, which employed PTT with DOX-loaded 
nanocrystals, more than doubled the toxicity of the FeCo/GC-Dox, causing more cell death 
than DOX in its free form with or without NIR irradiation. Similarly, Ma et al. demonstrated 
an approach for a combination therapy using GO–magnetic IONP hybrids for DOX delivery, 
PTT, and in vivo MR imaging in 4T1 tumor-bearing mice.231 Last, the codelivery of 
multiple anticancer drugs, camptothecin (CPT) and methotrexate (MTX), using IONP–GO 
hybrids in combination with NIR-induced PTT was recently demonstrated in vivo to achieve 
a tumor inhibitory rate of 73.9% in S-180 sarcoma-bearing Balb/c mice.232
Utilizing nanoparticles with varying compositions to construct graphene–hybrid 
nanostructures can permit enhanced effects upon photoirradiation. For instance, high 
photothermal energy conversion efficiencies have been reported for hybrids composed of 
gold nanostructures with GO or rGO.209,233 To this end, NGO-enwrapped AuNRs were 
observed to not only increase the solution temperature to above 60 °C within 3 min of NIR 
light exposure (808 nm, 4 W cm−2) but also had enhanced biocompatibility over CTAB-
coated AuNRs alone.234 At a higher power intensity of 6 W cm−2, the temperature of the 
solution (0.2 mg mL−1) increased to 75 °C within 2 min. The further loading of DOX and 
targeted delivery to hepatoma Huh-7 cells led to 82% cell death after NIR irradiation, which 
was about 1.5-fold and 4-fold more efficient than separate treatments of chemotherapy and 
PTT, respectively. However, by exploiting the unique luminescence properties of UCNPs, 
Zhang and co-workers reported a theranostic platform that afforded NIR-based imaging and 
both PTT and photodynamic therapy (PDT).235 While PTT uses light to induce local 
heating, PDT employs light to activate a photosensitive drug to facilitate the generation of 
reactive oxygen species. After covalently grafting the UCNPs with NGO, the 
nanocomposites were loaded with the photosensitizer phthalocyanine (ZnPc). These UCNP-
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NGO/ZnPc hybrids allowed for (1) imaging of cells and whole-body animals with 
upconversion luminescence, (2) conversion of 808 nm laser energy (2 W cm−2) into thermal 
energy for PTT (heating to 58 °C within 3 min), and (3) generation of cytotoxic singlet 
oxygen from ZnPc under 630 nm light exposure for PDT. Importantly, the authors found that 
a synergistic effect could be achieved due to the combination of noninvasive PDT and PTT, 
thereby improving therapeutic efficiency and decreasing the dose-limiting toxicity and tissue 
damage from overheating (50% and 75% cell viability for PDT and PTT alone, respectively, 
versus 15% when combined using UCNP-NGO/ZnPc hybrid). Such integrated platforms 
allow for the integration of diagnostics and therapies in a single nanocomposite.
Graphene-based MSNPs have also served as a reliable nanocomposite for multifunctional 
therapies. Wang et al. developed a mesoporous silica-coated graphene nanosheet for the 
targeted treatment of glioma cells.236 Mesoporous silica generated on GO sheets was highly 
loaded with DOX (1.27 μg of DOX per μg of composite), attributed to encapsulation within 
the mesopores as well as adsorption on the GO surface. As for the photothermal effects, 
irradiation with NIR light (808 nm, 6 W cm−2) caused the temperature of the nanocomposite 
solution (50 μg mL−1) to exceed 50 °C within 2 min. The surface was further modified with 
a targeting peptide against IL-13 protein, which targets the receptor chain 2 of interleukin 13 
that is overexpressed in malignant tumors including glioma. In vitro incubation with U251 
glioma cells showed that combining hybrid composite-based DOX delivery with NIR 
irradiation mediated the highest rate of cell death (combination index = 0.504 [<1]) as 
compared to a single treatment of the composite with DOX only (chemotherapy alone) or 
the composite with NIR irradiation only (PTT alone). In a more recent study, Wang et al. 
modified the above-described system to further incorporate MNPs (Fe3O4) for magnetic 
targeting and MRI.237 The targeting peptide-modified magnetic graphene-based mesoporous 
silica (MGMSPI) showed enhanced targeting with a magnet in glioma-bearing mice, and 
NIR-treated, DOX-loaded MGMSPI showed the maximal decrease in cell viability when 
administered to in vitro U251 cultures.
Finally, while MSNPs assembled on GO enhance drug loading due to the high surface area 
to volume ratio, further coating with amorphous carbon produced “nanocookie-like 
structures” that enabled on-demand, NIR-responsive chemotherapy and hyperthermia 
(Figure 36A–C).238 The loading capacity of a model hydrophobic drug, CPT, was found to 
be 0.878 mmol g−1, which was much higher than that for rGO (0.433 mmol g−1) and porous 
silica (0.336 mmol g−1). This is likely due to the affinity between CPT and the carbonaceous 
surface, along with the presence of the massive surface area from the porous SiNP support 
(~720 m2 g−1). Interestingly, irradiation with NIR light (808 nm, 2 W cm−2) not only 
induced local heating (due to GO), but also facilitated burst-like drug release. This feature 
proved to be critical to enhance combined therapy, in which in vitro studies with MDA-
MB-231 breast cancer cells revealed ~90% cell death with a total nanocookie-CPT 
concentration of 0.878 μM and 5 min of NIR irradiation. Further studies with nude mice 
bearing MDA-MB-231 tumor cells showed that the size of the tumor decreased in the 
nanocookie + NIR and nanocookie-CPT + NIR treated mice in the first 14 days, while it 
increased in other treatments (Figure 36D). In addition, after 14 days, the tumor size of 
nanocookie + NIR treated mice began to increase again, but the nanocookie-CPT + NIR 
treated mice showed a continual decrease in tumor size and the tumors eventually 
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disappeared after 30 days (Figure 36E). Overall, this type of recent work provides strong 
evidence that combining small molecule drugs, hyperthermia, and imaging in a single 
multifunctional graphene–nanoparticle composite can enhance cancer therapeutics.
4.5. Stem Cell and Tissue Engineering Approaches
Tissue engineering is a growing field of study that combines living cells and biocompatible 
materials to create constructs that can potentially repair or replace the function of living 
tissues and organs.239 In regard to living cells, stem cells are an attractive cell source for 
tissue engineering applications because they exhibit the ability to self-renew and 
differentiate into specific cell lineages. However, guiding stem cell differentiation toward a 
desired cell type tends to require precise control over the biochemical and physical 
microenvironmental cues. In this regard, engineering cellular microenvironments to promote 
stem cell attachment, growth, viability, and differentiation has been a major area of focus. 
As such, graphene has proven to be a promising candidate for stem cell engineering, 
exhibiting excellent biocompatibility and tunable functionalities for cultures of embryonic 
stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), 
and neural stem cells (NSCs).10a,240 Moreover, recent work has further explored ways to 
arrange graphene-based nanomaterials into three-dimensional architectures, with the goal of 
designing tissue-like transplantable scaffolds.241 With the increasing interest in adding 
greater functionality to cellular scaffolds, a handful of studies have investigated the potential 
of graphene–nanoparticle hybrids for stem cell and tissue engineering with great success.
Graphene-coated surfaces have been found to be conducive to protein attachment, 
potentially due the hydrophobic and hydrophilic patches that are found on the surface of 
proteins.242 As mentioned previously, an early study conducted by Deng et al. demonstrated 
the incorporation of proteins on the GO surface to efficiently assemble nanoparticles of 
different size, shape composition, and surface properties.102 Using BSA as a model protein, 
BSA-coated GO were used to assemble presynthesized metallic nanoparticles (Au, Pt, Pd, 
Ag) and/or nonmetallic nanoparticles (latex). The work concluded that multiple interactions 
mediated via specific chemical groups led to the adsorption of protein (e.g., cysteine, lysine, 
histidine residues) and that the GO surface could serve as a “universal adhesive” to facilitate 
the attachment of nanomaterials and potentially cells.
The nanoscale topography of hybrid surfaces can also present a unique extracellular 
microenvironment to control stem cell behavior (e.g., cell shape, adhesion, proliferation, and 
differentiation).243 For this purpose, nanotopographical substrates composed of rGO and 
positively charged polysaccharide chitosan have been fabricated with the hypothesis that the 
unique, biocompatible nanotopography could provide an effective environment for the 
differentiation of human MSCs.241b The mixture of rGO and chitosan at varying ratios (0–
5% w/w) produced nanoparticle-like composites, which, upon spin-coating onto bare glass 
substrates, introduced surface roughness that ranged from 0.9 to 7.7 nm. While it was 
observed that the presence of higher concentrations of graphene on the substrates decreased 
the proliferation rate of human MSCs, concentrations of less than 0.1 mg mL−1 had minimal 
cytotoxicity. On the other hand, cellular adhesion was found to be greatest on the 5% rGO–
chitosan substrates and provided a suitable environment for proliferation. These 
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nanocomposite substrates were further observed to enhance bone differentiation, both with 
and without osteogenic-induction media, as well as neurogenesis under neurogenic 
conditions. In this way, the unique nanoscale topographical cues of the graphene–chitosan 
nanocomposites are likely to play a crucial role for human MSC differentiation, although the 
exact mechanism is not yet understood. Along these lines, in a recent study from our group, 
Solanki et al. generated arrays of graphene–nanoparticle hybrid structures to guide the 
differentiation and alignment of human NSCs.244 Positively charged SiNPs (300 nm) were 
assembled on glass substrates using a centrifugation process, after which negatively charged 
GO was deposited (Figure 37A). These hybrid films were further coated with the 
extracellular matrix protein laminin to facilitate adhesion and growth of human NSCs. After 
2 weeks of culture, the graphene–nanoparticle hybrid nanostructures were observed to 
promote a higher efficiency of differentiation into the neuronal cell lineage. Interestingly, 
cellular extensions were seen to spread in a unidirectional manner after 5 days of culture. 
This axonal alignment was observed to be maximal on the hybrid films, in which the SiNP–
GO substrates showed the smallest variation in the angle of orientation of axons as 
compared to control substrates (Figure 37B). This behavior was further observed on hybrid 
films generated on flexible and biocompatible polymeric substrates, underscoring the 
potential of using the graphene–nanoparticle hybrids for guided neural tissue engineering. 
However, the authors note that further study is required to fully understand the underlying 
mechanisms governing the observed neuronal differentiation and axonal alignment.
Finally, an essential step in conducting stem cell studies is the ability to monitor the 
differentiation process and identify the stage of differentiation, which can give insight into 
the development of effective stem cell-based therapies. Many of the conventional techniques 
used to distinguish undifferentiated versus differentiated stem cells, such as immunostaining, 
fluorescence-activated cell sorting (FACS), and Western blotting, tend to be laborious, time-
consuming, and destructive. A graphene–nanoparticle platform based on SERS detection 
was recently shown to be an effective and highly sensitive tool that could distinguish 
undifferentiated and differentiated stem cells, while maintaining cell viability.245 In 
particular, GO-encapsulated AuNP films were generated on ITO surfaces, followed by use 
for the culture of mouse NSCs. On the basis of several reports, undifferentiated stem cells 
have been found to contain molecules bearing a high number of C=C bonds (high degree of 
saturation) as compared to differentiated cells.246 Given that such bonds have strong affinity 
to GO, the GO–Au nanoparticle films were effectively used to measure the SERS signal and 
distinguish such chemical heterogeneity between C=C bonds (1656 cm−1) and C–H bonds 
(1470 cm−1). By measuring differences in the SERS signal, the differentiation state of the 
NSCs was detected and validated via immunostaining. These results were further verified by 
detecting the electrochemical signals with CV in a microgap configuration containing GO–
AuNP films. As such, the use of GO–nanoparticle composites provided unique 
multifunctionalities wherein the GO–AuNP films could act as a biocompatible substrate for 
cell differentiation as well as SERS and electrochemical detection to provide a noninvasive 
and effective method for the in situ monitoring of stem cell differentiation.
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4.6. Biocompatibility of Graphene–Nanoparticle Hybrid Materials
Despite the recent rise in popularity of graphene–nanoparticle hybrid materials, for these 
materials to reach their full potential for bioapplications, especially those involving cellular 
interactions, they must first prove to be biocompatible both in vitro and in vivo. A limited 
number of studies have focused on the biocompatibility of graphene–nanoparticle hybrids; 
however, in this section, we will review what has been reported to date. In particular, we will 
begin by highlighting what is currently known about the biocompatibility of graphene 
materials in vitro and in vivo, where significantly more work has been performed. Following 
this, we will review the present understanding of the biocompatibility of graphene–
nanoparticle hybrid materials with a primary focus on in vitro studies utilizing mammalian 
cell models and preliminary in vivo studies, which have predominantly concentrated on the 
use of mouse models of human cancers.
4.6.1. Biocompatibility of Graphene Materials—A significant number of studies have 
investigated the biological effects of graphene and its derivatives.247 In particular, the 
biocompatibility of graphene materials has been found to depend significantly on their 
physicochemical properties (e.g., hydrophilicity, physical dimensions), concentration, time 
of exposure, and route of administration. In vitro, hydrophilic forms (e.g., GO) and small 
sizes of graphene are better able to penetrate the cell membrane, where they can translocate 
into organelles in the cytoplasm (e.g., lysosomes, mitochondrion, endoplasm, and nucleus),
248
 and are generally less toxic than hydrophobic forms (e.g., graphene and rGO) and larger 
sizes of graphene (Figure 38). For example, Wang et al. reported that the delivery of GO (up 
to 10 μg mL−1) only slightly decreases the viability of human fibroblast cells (less than 20% 
even when exposed for 4 days) (Figure 38A).248 However, as would be expected, increasing 
the exposure time and concentration of graphene led to further decreases in cell viability, 
where it was reported that GO concentrations above 50 μg mL−1 exhibited obvious 
cytotoxicity even after only 1 day of exposure (>20%).248 On the other hand, pristine 
graphene, which is highly hydrophobic, can also result in significant toxicity, wherein 
exposure of Vero cells to 10 μg mL−1 of pristine graphene for 24 h resulted in a 10–15% 
decrease in cell viability (as compared to <5% decrease for GO from Wang et al.’s study).
249
In terms of their ability to be uptaken by cells, possible explanations for the dependence of 
cell uptake on hydrophobicity include the fact that hydrophobic forms of graphene are 
hindered by both repulsive interactions as well as agglomeration in physiological medium. 
However, despite not being able to enter the cell, graphene can accumulate on the cell 
membrane resulting in membrane deformation, destabilization of the cytoskeleton, and 
intracellular stress, which may lead to apoptosis (Figure 38C and D). Fortunately, there are 
numerous methods available to improve the biocompatibility of hydrophobic derivatives of 
graphene including functionalization and/or coating the graphene with functional groups or 
polymers. For instance, Sasidharan and colleagues found that by making pristine graphene 
more hydrophilic via carboxyl functionalization, it was possible to significantly enhance its 
biocompatibility.249 In particular, carboxyl functionalization was achieved by treatment of 
graphene with mild acid. As a consequence, 24 h exposure of Vero cells to up to 300 μg mL
−1
 of this hydrophilic functionalized graphene did not significantly affect viability (<5% 
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decrease). Finally, despite the biocompatibility shown by hydrophilic forms of graphene, it 
should be mentioned that reports have claimed that all forms of graphene, regardless of their 
hydrophobicity, have the ability to generate reactive oxygen species in mammalian cells, 
which may lead to apoptosis and should be taken into consideration when using graphene 
materials.250
Graphene materials, especially GO, have also been shown to strongly promote cell adhesion. 
In particular, numerous studies have utilized graphene and its derivatives as substrates for 
the culture of various cell types including stem cells (e.g., iPSCs, NSCs). In the case of 
NSCs, Park et al. offered the first demonstration that laminin-coated graphene could enhance 
and increase the differentiation of human NSCs into neurons rather than glial cells, which 
occurred in the absence of added biochemical motifs.240c Of particular importance, the 
authors found that culturing NSCs on graphene did not negatively affect their proliferation 
or their differentiation ability. Similarly, a number of studies have utilized rGO substrates to 
culture and differentiate human NSCs into neurons.251 As with Park et al.’s study, it was 
found that rGO did not affect proliferation or differentiation capability and, in fact, 
accelerated the differentiation of NSCs into neurons.251 Besides NSCs, Chen and co-
workers demonstrated that both graphene and GO could support mouse iPSC culture and 
allowed for spontaneous differentiation. Specifically, in comparison to glass substrates, 
iPSCs grown on graphene were found to exhibit similar degrees of cell adhesion and 
proliferation, while iPSCs cultured on GO adhered and proliferated at a faster rate. 
Interestingly, graphene was found to favorably maintain the iPSCs in an undifferentiated 
state. On the contrary, GO expedited the differentiation process resulting in ectodermal and 
mesodermal lineages, wherein it was reported that GO augmented endodermal 
differentiation while graphene tended to suppress iPSC differentiation toward this lineage.
240a
Besides hydrophobicity, the size of the sheets also plays a major role in their 
biocompatibility. To determine the relationship between size and biocompatibility, Liao and 
coworkers fabricated graphene as well as different sized GO sheets via sonication (from 342 
to 765 nm) and tested their biological effect on red blood cells (RBCs) and human 
fibroblasts.250a It was found that all of the GO and graphene sheets exhibited dose-
dependent hemolytic activity on RBCs. In the case of the GO samples, the size played a 
critical role in the extent of hemolysis, wherein smaller GO sheets exhibited higher 
hemolytic activity than larger GO sheets. As compared to the GO sheets, which are better 
dispersed due to their high surface oxygen content, graphene tended to aggregate and 
showed lower hemolytic activity. Interestingly, covering the GO sheets with chitosan 
eliminated their hemolytic activity, further demonstrating that coating and functionalization 
of graphene materials plays a significant role in their biocompatibility. Finally, the authors 
confirmed that GO was more biocompatible than graphene when incubated with human 
fibroblasts but did not study the effect of size on biocompatibility in these cells.
In vivo, the majority of studies have reported that there are no significant side effects (e.g., 
no occurrences of animal death) when graphene materials are administered into mouse 
models; however, some studies have reported accumulation as well as inflammation and, in 
rare cases, fibrosis. In addition to physicochemical properties, concentration, and exposure 
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time, which were mentioned previously for in vitro biocompatibility, the administration 
route of graphene materials and the characteristics of the animals used also significantly 
affect the biocompatibility of graphene. Most studies report no occurrence of adult animal’s 
death, even for graphene material doses up to 10 mg kg−1.44a,252 For instance, Wang et al. 
reported that the injection of 4–10 mg kg−1 of GO showed no signs of toxicity.248 However, 
one-half of the mice treated with >15 mg kg−1 died within 7 days of injection. 
Histopathology revealed that major airways in the lung were blocked by GO conglomeration 
leading to suffocation in 15% of the GO-administered mice. Further investigation 
determined that when administered intravenously, GO also generally accumulated in the 
reticuloendothelial system (RES) such as the liver and spleen, which had been confirmed in 
other studies as well.44a,248,253 In mice that did survive high doses of GO administration, the 
mice appeared weak and lost 10% of their body weight within the first week following 
administration, but symptoms disappeared after 1 week as evidenced by normal eating and 
weight. This could be explained by fecal elimination of accumulated graphene materials via 
bile as well as renal elimination when the graphene materials had a sufficiently small size.
248,253
 Finally, in terms of the rate of clearance of graphene materials based on size, small 
size graphene sheets (single sheets with diameter of 10 nm or less) were found to have a t1/2 
(elimination half-life) close to 0.4 h, while the t1/2 values for larger sheets were observed to 
be greater than 5 h.253,254 It should also be noted that the functionalization and/or coating of 
graphene materials makes a significant difference on their in vivo biocompatibility. For 
example, Yang and colleagues determined that even 20 mg kg−1 of PEGylated graphene did 
not cause appreciable toxicity in mice during a period of three months as evidenced by blood 
biochemistry, hematological analysis, and histological examinations.253
Overall, graphene materials appear to be biocompatible depending on their physicochemical 
properties (e.g., more hydrophilic), concentration, time of exposure, and route of 
administration. Moreover, functionalization and polymer coatings (e.g., chitosan, 
PEGylation) can enhance biocompatibility. However, graphene materials are nondegradable 
materials with great potential for cellular internalization. As such, more detailed 
characterization and investigation of the long-term adverse effects of graphene materials 
remains to be fully elucidated before they can be readily applied in the clinic.
4.6.2. Biocompatibility of Graphene–Nanoparticle Hybrid Materials—For 
graphene–nanoparticle hybrid materials, there are currently limited biocompatibility studies 
available; however, preliminary results have fallen in line with the biocompatibility seen 
with graphene materials and, as such, are promising. Currently, the majority of the studies 
reporting biocompatibility for graphene–nanoparticle hybrids have primarily focused on 
graphene–MNP hybrids. Studies using this type of graphene–nanoparticle hybrid have 
indicated that these hybrids are biocompatible up to iron concentrations as high as 80 μg mL
−1
.
194,197
 In particular, Chen et al. determined that HeLa cells could be incubated with GO-
Fe3O4 MNP composites with different iron concentrations of 10, 20, 40, and 80 μg mL−1 
while maintaining low cytotoxicities (100%, 96%, 92%, and 91% cell viability, 
respectively).194 This was confirmed by Chen and co-workers wherein drug delivery and 
optical imaging were demonstrated using DOX-GO-PEG-β-FeOOH nanocomposites.195 
Moreover, fluorescence images that were taken of HeLa cells incubated with DOX-GO-
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PEG-β-FeOOH for 24 h indicated that the DOX loaded on GO-PEG-β-FeOOH primarily 
remained in the cytoplasm, where the DOX was released and subsequently found to 
accumulate in the cell nuclei after 36 h of incubation. Finally, Yang and colleagues reported 
that their rGO-IONP-PEG nanocomposites were biocompatible both in vitro and in vivo and 
that they could be used for image-guided PTT.207 In particular, their preliminary in vivo 
results suggested that PEGylated graphene-based nanocomposites (up to 200 uL of 20 mg 
mL−1 solution injected intravenously) showed no obvious toxicity in mice (mice bearing 
4T1 tumors in their right shoulders) with most accumulation occurring in the RES (e.g., liver 
and spleen) and the tumor (Figure 39A and B), when followed for at least 2 weeks.
Graphene nanoparticle hybrid materials composed of noble metal (e.g., Ag and Au) 
nanoparticles and graphene and its derivatives have also proven to be biocompatible. For 
instance, for GO–AgNP hybrids, a cell viability of 95% was obtained following exposure of 
A549 (adenocarcinoma human alveolar basal epithelial) cells to 1 mg mL−1 of the GO–
AgNPs for 24 h.254 Moreover, due to the properties of graphene–noble metal nanoparticle 
hybrids, they offer the ability to act as a SERS agent. As such, a number of studies have 
utilized these hybrids to study the specific cell uptake mechanism of graphene–nanoparticle 
hybrids as well as to determine their cellular distribution. From these studies, it was 
determined that GO–noble metal nanoparticle hybrids are generally uptaken via clathrin-
mediated, energy-dependent endocytosis and are then distributed in the cytoplasm.179,198,255 
In particular, Huang and colleagues used GO–AuNPs to study the mechanisms of cellular 
uptake of graphene–hybrid materials in Ca Ski cells via SERS.255 In this work, the authors 
reported that, in addition to distribution throughout the cytoplasm, the graphene–
nanoparticle hybrids could not cross the nuclear membrane. Moreover, cell uptake was 
detectable (via SERS) starting 4 h after incubation with GO–AuNPs, reached a maximum 
after 6 h, and weakened thereafter, until the signal was barely above noise level (by 12 h of 
incubation). This suggested that the AuNPs, which were covalently conjugated via 
EDC/NHS coupling, may have been released from the GO sheets in the cellular 
environment. In vivo, GO-IONP-Au-PEG hybrids were intratumorally injected at a 
concentration of 50 ug mL−1 (40 uL) into subcutaneous 4T1 tumor bearing BALB/c mice. 
While cytotoxicity was not studied in particular, the authors reported no side effects and a 
similar growth speed for tumors in hybrid-injected and control mice.211
Reports on MSNP–GO hybrid materials also suggest that these graphene–nanoparticle 
hybrids are biocompatible for both in vitro and in vivo cell studies. In vitro, MSNP–GO 
hybrids did not exhibit considerable cytotoxicity at low to moderate concentrations (1–100 
μg mL−1). For example, He and colleagues confirmed the biocompatibility of FA-targeted 
MSNP–GO nanoparticles.224 In this case, the mesoporous silica shell was loaded with DOX 
and whose release was controlled by photoinduced pH activation. In the absence of 
activation, the MSNP–GO hybrids were biocompatible up to 100 μg mL−1 with HeLa and 
L02 cell viability being maintained above 80% after 24 h of incubation. Moreover, the 
authors found that the FA-targeted hybrids exhibited selective cell internalization via 
receptor-mediated endocytosis. Similarly, Sreejith et al. reported that MSNP–GO hybrids 
loaded with squaraine dyes were also biocompatible but at a lower dose (incubation of 1 μg 
mL−1 in HeLa cells for 24 h resulted in a >80% viability).202 In vivo, nude mice have been 
shown to be able to withstand up to 5 mg kg−1 of MSNP–GO hybrids without any reported 
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toxicities. In this case, Chen et al. demonstrated that their nanocookies (5 mg kg−1 via 
intravenous injection), as described in a previous section, could be used to effectively release 
CPT and induce PTT therapy, thereby eradicating subcutaneous MDA-MB-231 breast 
tumors in nude mice.238 In particular, the tumors were found to have disappeared 14 days 
post treatment and did not reappear again even after 2 months, demonstrating the prolonged 
biocompatibility of their platform. Moreover, no significant toxicities (e.g., weight loss, 
change in behavior) were reported. Last, in support of these findings, Wang and colleagues 
determined that their targeting peptide-modified MGMSPI, which were loaded with DOX, 
were also well-tolerated following intraperitonial injection in nude mice bearing intracranial 
U251 brain tumors at doses up to 6 mg mL−1 (150 uL).237
Finally, although less has been reported on the biocompatibility of other types of graphene–
nanoparticle hybrids, GO–UCNP and GO–QD hybrids have been demonstrated to be 
biocompatible. In the case of GO–UCNPs, HeLa cells and KB (human nasopharyngeal 
epidermal cancer) cells incubated with NGO–UCNP concentrations as high as 320 mg mL−1 
for 24 h resulted in cell viabilities higher than 90%.236 In vivo injection was also performed, 
where it was found that subcutaneous injection of 200 μg mL−1 of NGO–UCNPs into white 
Kunming mice caused no significant toxicities and could be used for NIR-mediated imaging 
and PTT/PDT cancer therapy. On the other hand, GO–QDs have also been found to be 
biocompatible but at a lower concentration than for GO–UCNPs.204,212 Sheng and co-
workers found that AIZS-GO-PEG hybrid nanoparticles were biocompatible in NIH/3T3 
cells (mouse fibroblasts) when incubated for 24 h at concentrations up to 100 mg mL−1.204 
Similarly, Hu et al. found that the viability of HeLa cells remained high (92%) after 
exposure to 20 mg L−1 of rGO–QD nanocomposites (CdSe/ZnS QDs) for 12–48 h.212 In 
addition, uptake of the QD–rGO composites into the cytoplasm of the HeLa cells could be 
clearly visualized, wherein it was found that US-rGO (38 nm) localized throughout the 
cytoplasm while S-rGO (260 nm) was mainly found on the cell surface (Figure 39C–G). 
Importantly, the authors reported that the QD–rGO composites appear to be localized as 
discrete dots within the HeLa cells following incubation, suggesting a lack of QD leaching 
from the nanocomposites.
Overall, although in depth and long-term in vivo studies still remain to be performed, 
preliminary results suggest that graphene–nanoparticle hybrids composed of GO tend to be 
highly biocompatible, which may be by virtue of their highly hydrophilic nature as well as 
the coatings used (e.g., PEGylation). It should be noted that the majority of the studies 
performed for graphene–nanoparticle hybrid materials have used cancer cell lines. While the 
results are promising, these cell lines tend to be more resistant to apoptotic cell death, and, 
as a result, this must be taken into consideration when evaluating the reported findings. 
Looking forward, to accelerate the translation of graphene–nanoparticle hybrids to the clinic, 
there is a need for more detailed studies looking at the biocompatibility of different 
graphene–nanoparticle composites with a variety of properties including the size of the 
nanoparticles, size of the graphene sheets, concentration, surface charge and/or coating, and 
long-term stability and in vivo fate.
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5. CONCLUDING REMARKS AND FUTURE PERSPECTIVES
Graphene is a fascinating material that has garnered ever-increasing interest from the 
scientific community over the past decade. Because of its exceptional properties, graphene is 
already being used in a wide variety of applications including electronics, energy, sensing, 
and even bioapplications such as biosensors, drug delivery, stem cell differentiation, and 
cellular imaging. However, in the last several years, the incessant search for new avenues 
that would benefit from graphene has led to the advent of graphene–nanoparticle hybrid 
structures, which combine the unique and advantageous properties of nanomaterials/
nanotechnology with those of graphene to produce advantageous and often synergistic 
effects. In this Review, we have sought to provide insight into the synthesis and 
characterization of graphene–nanoparticle hybrid materials as well as their implementation 
to a host of bioapplications that fall into two general categories: (1) biosensing and (2) 
cellular applications such as imaging, PTT, multifunctional drug delivery, and the control of 
stem cell differentiation.
In terms of the synthesis of graphene–nanoparticle hybrids, numerous avenues are currently 
available for the preparation of hybrids composed of graphene-based nanomaterials and 
various nanoparticles. These include in situ (e.g., reduction, hydrothermal, and 
electrochemical) and ex situ (e.g., covalent, electrostatic, and π–π stacking) methods. 
However, the optimal method depends greatly on the requirements of the desired 
application. For example, in biosensing applications, wherein the electrical properties of 
graphene in the graphene–nanoparticle hybrids should be maximized, noncovalent ex situ 
methods such as electrostatic interactions and π–π stacking are most desirable as the use of 
presynthesized nanoparticles eliminates any possible incompatibilities between nanoparticle 
synthesis and assembly as well as any alterations to the structure of graphene. On the other 
hand, in situ methods require less time and fewer steps to complete and can be used in 
applications where a narrower size distribution as well as precise control over the size, 
shape, and density of the nanoparticles that decorate the graphene sheets is unnecessary. For 
instance, most cellular applications such as stem cell differentiation, drug delivery, or 
cellular imaging do not require maximizing the electrical properties of the hybrids and, as 
such, have used in situ methods. It should be noted that ex situ methods have also been used 
for cellular application, especially for stem cell differentiation as well as applications using 
graphene-encapsulated nanoparticles.
As for the bioapplications of graphene–nanoparticle hybrids, these structures have mainly 
been applied to biosensing and biomedicine. In the case of biosensing, we covered three 
main types: (1) electronic, (2) electrochemical, and (3) optical. These biosensors, which 
each have their own advantages and disadvantages, have all benefited from the application of 
graphene–nanoparticle hybrids with achievable sensitivities and selectivities that are 
comparable to or better than gold standards including other carbon-based nanomaterials. In 
particular, electronic sensors wherein graphene–nanoparticle hybrids are applied to FET-
based devices can currently achieve the highest sensitivity with a LOD in the attomolar 
range. In addition, the use of hybrids provides enhanced surface area for analyte binding 
while amplifying the achievable signal and electrical conductivity. Hybrid sensors that 
utilize optical mechanisms also have great promise as they can potentially allow for the 
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detection of single molecules (e.g., SERS) as well as the quantification of molecules in 
living cells in a nondestructive manner (e.g., FRET and SERS). Similarly, although hybrid 
electrochemical sensors lag behind in terms of their achievable sensitivity, they allow for 
direct conversion of a biological recognition event to an electrical signal at a low cost and 
complexity. Moreover, hybrid structures can help overcome the poor utilization coefficient 
of aggregated nanoparticles as well as improve the electron transfer that occurs between the 
analyte and the electrode. Finally, graphene–nanoparticle hybrid structures offer the ability 
to develop novel sensing mechanisms. For example, our group has recently developed a 
label-free polypeptide-based biosensor for enzyme detection using a graphene–AuNP 
composite (Figure 40).110 In this platform, graphene was first deposited between Au 
electrodes. A layer of functional polypeptide linker followed by AuNPs was then assembled 
on the graphene layer. In this way, enzymatic degradation of the functional polypeptide 
linker by the enzyme of interest resulted in release of the AuNPs and a measurable shift in 
electrical hysteresis. Using this method, we achieved the sensitive (LOD 1 μM) and selective 
detection of Carboxypeptidase B, a predictor for severe acute pancreatitis. In terms of its 
mechanism, the AuNPs assembled on the graphene surface using a functional polypeptide 
linker have the ability to store charge resulting in a measurable hysteresis upon their release 
from the device surface.
For graphene–nanoparticle hybrid application to biomedicine, we covered five topics of 
interest: (1) bioimaging, (2) PTTs, (3) drug/gene delivery, (4) combined multifunctional 
therapies, and (5) stem cell/tissue engineering. In this case, graphene–nanoparticle hybrid 
materials show immense potential due to their intrinsic unique physical, chemical, magnetic, 
electrical, plasmonic, and mechanical properties. Specifically, similar to the case with 
biosensors, the application of graphene–nanoparticle hybrids has seen great success with 
different combinations being used to attain different multi-functionalities of interest. 
Therefore, graphene–nanoparticle hybrids have led to the enhancement of image contrast, 
cancer therapies, and stem cell differentiation.
While the future prospects of graphene–nanoparticle hybrids are very bright, our ability to 
synthesize graphene and its derivatives with controllable sizes, shapes, and defects at a low-
cost and high-yield manner as well as our ability to control the size, composition, 
morphology, and crystallinity of the various incorporated nanoparticles remain critical 
bottlenecks to the advancement of graphene–nanoparticle hybrids. Moreover, while 
significant progress has been made to achieve precise control over the density and specific 
arrangement of nanoparticles that are assembled on graphene and its derivatives, there is still 
significant room for improvement. As such, there is a need to gain a deeper understanding of 
the underlying mechanism of graphene–nanoparticle formation to better control their 
synthesis, assembly, and adhesion. This is especially true for biosensing and imaging 
applications wherein the nanostructure and charge transfer behavior are particularly 
important. This will also allow for better control over stem cell differentiation, the 
distribution and targeting of hybrids in the body, as well as lower the limits of achievable 
sensitivity and selectivity for biosensing. Finally, significant investigation will be required to 
assess the toxicity and biodistribution of such hybrid material in vivo as well as the targeting 
of nanocomposites to improve the efficacy of treatments and reduce off-site toxicity. In 
addition to biodistribution and long-term safety, understanding the cellular interaction and 
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the precise mechanism of action guiding changes in cellular behavior is equally important 
for regenerative medicine and tissue engineering.
In conclusion, we have highlighted an up-and-coming field wherein graphene–nanoparticle 
hybrid structures can bring synergistic advantages to a wide variety of bioapplications. 
While promising, the field of graphene–nanoparticle hybrids remains in its infancy, and a 
number of challenging issues must be addressed before its maximum potential can be 
achieved. Moreover, we imagine that the maturation of this technology will result in the use 
of graphene–nanoparticle hybrids in a much broader range of bioapplications, while the 
high-quality and large-scale fabrication of graphene–nanoparticle hybrids will minimize 
costs and lead to its commercialization. We hope that this Review has inspired interest from 
various disciplines that will benefit from the development of graphene–nanoparticle hybrids 
for bioapplications.
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2D two-dimensional
5-FU fluorouracil
AA ascorbic acid
AFM atomic force microscopy
AFP alpha fetoprotein
AgNP silver nanoparticle
AIZS zinc-doped AgInS
aM attomolar
APTES (3-aminopropyl)triethoxysilane
AuNP gold nanoparticle
AuNR gold nanorod
AuNS gold nanoshell
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BSA bovine serum albumin
CEA carcinoembryonic antigen
CMG chitosan magnetic–graphene nanocomposite
CNT carbon nanotube
conA concanavalin A
CPT camptothecin
CT computed tomography
CV cyclic voltammetry
CVD chemical vapor deposition
DA dopamine
DOPC dioleoyl-sn-glycero-3-phosphocholine
DOX doxorubicin
EDC 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide
EGFR epidermal growth factor receptor
EP electrophoretic preconcentration
ERGO electrochemically reduced graphene oxide
ESCs embryonic stem cells
FA folic acid
FACS fluorescence-activated cell sorting
FB1 fumonisin B1
FET field-effect transistors
fM femtomolar
FR folate receptor
FRET fluorescence resonance energy transfer
GC graphitic carbon shell
GCE glassy carbon electrode
GFP green fluorescent protein
GNC gold nanocluster
GO graphene oxide
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GSGHs graphene–mesoporous silica–AuNP hybrids
hCG human chorionic gonadotrophin
HER2 human epidermal growth factor receptor 2
HRP horseradish peroxidase
HUVEC human umbilical vein endothelial cells
ID injected dose
IGAuNPs intracellularly grown gold nanoparticles
IgG immunoglobulin G
IgM immunoglobulin M
IONP iron oxide nanoparticle
iPSCs induced pluripotent stem cells
ITO indium tin oxide
LOD limit of detection
LSPR localized surface plasmon resonance
MB molecular beacon
MGMSPI magnetic graphene-based meosporous silica
MGPNs multilayered graphene petal nanosheets
MNP magnetic nanoparticle
MRI magnetic resonance imaging
MSCs mesenchymal stem cells
MSNP mesoporous silica nanoparticle
MTX methotrexate
MUA 11-mercaptoundecanoic acid
NHS N-hydroxysuccinimide
NIR near-infrared
NMR nuclear magnetic resonance
NSCs neural stem cells
NSET nanometal surface energy transfer
OTA ochratoxin A
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PAG photoacid generator
PBA 1-pyrenebutyric acid
PBS phosphate-buffered saline
PCR polymerase chain reaction
PDDA poly(diallyldimethylammonium chloride)
PDT photodynamic therapy
PEGylated polyethyelene glycol-coated
PEI polyethylenimine
pM picomolar
PPGA PEGylated, polyethylenimine-grafted graphene/Au composites
PTBO poly(toluidine blue O)
PtNP platinum nanoparticle
PTT photothermal therapy
PVP polyvinylpyrrolidone
QDs quantum dots
r2 relaxivity rate
RBCs red blood cells
RES reticuloendothelial system
rGO reduced graphene oxide
S-rGO small reduced graphene oxide
SALDI-MS surface-assisted laser desorption/ionization mass spectrometry
SCE saturated calomel electrode
SERS surface-enhanced Raman spectroscopy
SiNPs silica nanoparticles
siRNA small interfering RNA
ssDNA single-stranded DNA
T1 spin–lattice longitudinal relaxation time
t1/2 elimination half-life
T2 spin–spin transverse relaxation time
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Trf transferrin
TRGO thermally reduced graphene oxide
UA uric acid
UCNPs upconversion nanoparticles
US-rGO ultrasmall reduced graphene oxide
UV ultraviolet
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Figure 1. 
Graphene nanoparticle hybrids exist in two forms, as graphene–nanoparticle composites and 
graphene-encapsulated nanoparticles, and can be used for various bioapplications including 
biosensors, photothermal therapies, stem cell/tissue engineering, drug/gene delivery, and 
bioimaging. Panel (A) reprinted with permission from ref 110. Copyright 2012 Wiley. Panel 
(B) reprinted with permission from ref 211. Copyright 2013 Elsevier. Panel (C) reprinted 
with permission from ref 244. Copyright 2013 Wiley.
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Figure 2. 
Graphene–nanoparticle hybrid structures. Panels (A) and (B) show graphene-nanoparticle 
composites wherein nanoparticles are decorated on the surface of graphene sheets. Panel (A) 
reprinted with permission from ref 146. Copyright 2011 Elsevier. Panel (B) reprinted with 
permission from ref 102. Copyright 2010 American Chemical Society. Panels (C) and (D) 
show graphene-encapsulated nanoparticles wherein nanoparticles are wrapped by graphene. 
Panel (C) reprinted with permission from ref 112. Copyright 2012 American Chemical 
Society. Panel (D) reprinted with permission from ref 104. Copyright 2010 Wiley.
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Figure 3. 
The number of publications utilizing graphene–nanoparticle hybrid materials is increasing 
(numbers were obtained from PubMed).
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Figure 4. 
Methods for the mass-production of graphene. There are several choices depending on the 
particular application, each with differences in terms of size, quality (e.g., presence of 
defects and impurities), and price. Reprinted with permission from ref 1c. Copyright 2012 
Nature.
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Figure 5. 
Structure of graphene oxide and reduced graphene oxide. (A) Chemical structure of GO. (B) 
Scanning tunneling microscope (STM) image of a GO monolayer on a highly oriented 
pyrolytic graphite substrate. Oxidized regions are marked by green contours. Panel (B) 
reprinted with permission from ref 5b. Copyright 2007 American Chemical Society. (C) 
Chemical structure of rGO. Panels (A) and (C) reprinted with permission from ref 24. 
Copyright 2010 Wiley.
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Figure 6. 
Graphene–nanoparticle composite composed of GO sheets decorated with AuNPs. (A) AFM 
image of a single GO sheet and (B) a GO sheet decorated with 3.5 nm AuNPs. The 
corresponding curves on the right side show the thicknesses of the GO sheet and the GO/
AuNP sheet. (C and D) TEM images of the GO/AuNP sheet with different magnifications. 
Inset of (D) shows a high-resolution TEM image of a single AuNP. Reprinted with 
permission from ref 41. Copyright 2013 American Chemical Society.
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Figure 7. 
Graphene–bimetallic nanoparticle composites. (A) Procedure to fabricate graphene 
nanosheet/Pt-on-Pd bimetallic nanodendrite hybrids. (B) TEM images of the graphene–
bimetallic nanoparticle composites. Inset of (B) shows the Pt-on-Pd bimetallic nanodendrites 
at a higher magnification. Reprinted with permission from ref 49. Copyright 2010 American 
Chemical Society.
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Figure 8. 
Graphene–quantum dot composites. SEM images of the as-prepared samples of (A) CdS–
5% graphene, (B) CdS–30% graphene, and (C) UV–vis diffuse reflectance spectra of the 
samples of blank-CdS and Cd-GR nanocomposites with different weight addition ratios. 
Reprinted with permission from ref 73. Copyright 2011 American Chemical Society.
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Figure 9. 
Hydrothermal methods to synthesize graphene–AgNP composites. (A) (1) GO is adsorbed 
on the APTES-modified SiOx substrate. (2) GO is reduced, and rGO is obtained. (3) Growth 
of Ag particles by heating the rGO substrate in 0.1 M AgNO3 at 75 °C for 30 min. (4) 
Growth of AgNPs by heating the GO substrate in 0.1 M AgNO3 at 75 °C for 30 min. (B) 
Tapping mode AFM topographic image and height profile of a single layer of GO adsorbed 
on an APTES-modified SiOx substrate. (C) SEM image of Ag particles grown on a rGO 
surface. Reprinted with permission from ref 74b. Copyright 2009 American Chemical 
Society.
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Figure 10. 
Electrochemical deposition of Cu nanoparticles on rGO. (A) Electrochemical experiments 
were performed by an electrochemical workstation (CHI600C, CH Instrument Inc., U.S.) in 
a conventional three-electrode electrochemical cell. The rGO electrode, a Pt mesh, and an 
Ag/AgCl (3 M NaCl) electrode were used as the working, counter, and reference electrodes, 
respectively. (B) SEM image of Cu electrodeposited on a rGO electrode in 50 mM CuSO4 
solution at −0.6 V. (C) SEM image of Cu electrodeposited on a rGO electrode in 10 mM 
CuSO4 solution at −0.6 V. Reprinted with permission from ref 81. Copyright 2011 American 
Chemical Society.
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Figure 11. 
Protein-induced reduction and decoration of GO for the assembly of multiple nanoparticles. 
(A) General scheme depicting the BSA protein-based decoration and reduction of GO, 
leading to a general nanoplatform for nanoparticle assembly. (B) TEM images of AuNP 
decorated BSA–GO with well-controlled densities of AuNPs. (B and C) AuNP densities 
were varied by increasing the concentrations of BSA from 0.5 mg/mL (B) to 20 mg/mL (C), 
during the preparation of BSA–GO. NaCl was omitted for the samples in (B) and (C). (D) 
AuNP density was further increased (in comparison with (C)) by adding 0.1 M NaCl to the 
assembly system as in (C). Reprinted with permission from ref 102. Copyright 2010 
American Chemical Society.
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Figure 12. 
Fabrication process for graphene-coated NPs. Schematic diagram of GO assembly on amine-
functionalized NPs and TEM image of NPs coated with GO (inset: zoomed-out TEM image 
of NPs coated with GO). Reprinted with permission from ref 101b. Copyright 2011 Wiley.
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Figure 13. 
Crumpled graphene-encapsulated Si nanoparticles. (A) Schematic drawing illustrating 
aerosol-assisted capillary assembly of crumpled-graphene-wrapped Si nanoparticles. 
Aqueous dispersion of GO and Si particles was nebulized to create a mist of aerosol 
droplets, which were passed through a preheated tube furnace. During evaporation, GO 
sheets first migrated to the surface of the droplets and then tightly wrapped the Si particles 
upon complete evaporation. (B) SEM image showing the crumpled capsules of graphene-
wrapped Si. Reprinted with permission from ref 112. Copyright 2012 American Chemical 
Society.
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Figure 14. 
Protein detection using thermally reduced graphene oxide (TRGO) sheets decorated with 
gold nanoparticle–antibody conjugates. (A) Schematic of a TRGO FET. Anti-IgG is 
anchored to the TRGO sheet surface through AuNPs and functions as a specific recognition 
group for IgG binding. The electrical detection of protein binding is accomplished by FET 
and direct current measurements. (B) Sensor sensitivity (relative resistance change, %) 
versus IgG concentration. Dashed line represents the noise level from the buffer solution. 
Reprinted with permission from ref 124. Copyright 2010 Wiley.
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Figure 15. 
Electronic graphene–nanoparticle composite sensor utilizing aptamers to detect anthrax 
toxin. (A) Schematic illustration of the aptamer-immobilized graphene FET for detection of 
protective antigen (PA). (B) Vg,min shift (ΔVg,min) versus PA concentration in PBS solutions 
with different probe molecules. The ΔVg,min value was obtained by calculating the 
difference in the charge neutrality point, Vg,min, as a reference for the device with no binding 
of PA. Reprinted with permission from ref 127b. Copyright 2013 Wiley.
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Figure 16. 
Real-time detection of cancer marker, HER2, using a graphene-encapsulated nanoparticle-
based FET biosensor. (A) The preparation of the rGO–NP device. (B) Surface 
functionalization of rGO for immobilizing the antibody. (C) Measuring conductance of the 
devices when the target protein is introduced. (D) The sensitivity of the biosensor (relative 
conductance change, %) in response to the concentration of HER2 with VDS (voltage drain 
to source) = 1 V and Vg (gate voltage) = 0 V. (E) The selectivity of the biosensor in response 
to PBS buffer, BSA with 50 μg mL−1, and HER2 (100 pM and 1 μM). (F) Sensor sensitivity 
(relative conductance change, %) as a function of the HER2 concentration with VDS = 1 V 
and Vg = 0 V. All experiments were performed multiple times (sample number, n = 30) to 
collect statistical data (with error bars) and confirm the reproducibility and robustness of the 
biosensing system. Reprinted with permission from ref 101b. Copyright 2011 Wiley.
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Figure 17. 
Label-free electrochemical graphene–palladium nanoparticle nanocomposite-based 
immunosensor for alpha fetoprotein. (A) Schematic illustration for the preparation of Pd 
nanoparticles conjugated with rGO. (B) Differential pulse voltammetric response for the 
modified electrode toward different concentrations of AFP in 0.01 M phosphate buffer (pH 
7.4); pulse period, 0.2 s; amplitude, 50 mV. (C) Calibration curves of Pd–rGO modified 
immunosensor to different concentrations of AFP, error bar = relative standard deviation (n = 
5). Reprinted with permission from ref 143. Copyright 2014 Elsevier.
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Figure 18. 
Electrochemical DNA sensor. (A) Schematic diagram. In a typical experiment, captured 
probe 1 (cDNA1) was adsorbed on the surface of a graphene-modified glassy carbon 
electrode directly (a), followed by a further adsorption of blocking probe (bDNA) (b). 
Different target sequences (c) and AuNPs-modified oligonucleotide probes (d) were then 
cohybridized to the target-active substrates in buffer solution. After silver staining (e) on 
AuNPs tags as a signal amplification method, a subsequent differential pulse voltammetry 
(DPV) technique was applied as a detection means for deposited silver. The magnitude of 
the anodic peak current, which corresponds to the oxidation of silver particles, reflected the 
amount of complementary target oligonucleotides bound to the GCE-GR/cDNA1 surface. 
(B) DPV responses of the electrochemical DNA sensor in the blank, noncomplementary 
sequence, single-base mismatch sequence, and complementary sequence. Electrolyte: 0.1 M 
KNO3. Pulse amplitude: 50 mV. Pulse period: 0.2 s. Silver staining time: 10 min. Reprinted 
with permission from ref 145. Copyright 2011 Royal Society of Chemistry.
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Figure 19. 
Detection of DNA using a novel parallel-motif DNA triplex system and graphene–
mesoporous silica–gold nanoparticle hybrids. (A) Schematic procedure for the synthesis of 
graphene–mesoporous silica–gold nanosheets. (B) Illustration of the procedure for preparing 
the electrochemical sensing interface. (C) The procedure of strand-displacement DNA 
polymerization amplification and parallel-motif DNA triplex amplification. (D) TEM image 
of graphene–mesoporous silica hybrids. (E) The differential pulse voltammetric response to 
target DNA with different concentrations: (a) 0 M, (b) 10−14 M, (c) 10−13 M, (d) 10−12 M, 
(e) 10−11 M, (f) 10−10 M, and (g) 10−9 M. (F) The effect of probe currents on different 
concentrations of target DNA (from 10−14 to 10−9 M). Inset: A good linear detection range 
from 10−14 to 10−10 M was obtained. Reprinted with permission from ref 146. Copyright 
2011 Elsevier.
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Figure 20. 
Electrochemical detection of carbohydrates. (A–C) Schematics illustrating the fabrication 
process of a graphene–copper nanoparticle composite paste electrode. (D) Cyclic 
voltammograms at (a) a graphene–copper nanoparticle composite paste electrode, (b) a 
copper nanoparticle paste electrode, (c) a graphite–copper nanoparticle composite paste 
electrode, and (d) a graphene paste electrode in 75 mM NaOH aqueous solution containing 2 
mM glucose. Scan rate, 50 mV/s. The content of paraffin oil in the four pastes was 25% 
(w/w). Panels (A)–(D) reprinted with permission from ref 150. Copyright 2012 American 
Chemical Society. (E) Photograph of a magnetic electrode and (F) TEM image of graphene–
NiNP hybrid: (a) NdFeB magnet; (b) glass tube; (c) copper wire; and (d) graphite–epoxy 
composite. Panels (E) and (F) reprinted with permission from ref 151. Copyright 2013 
Elsevier.
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Figure 21. 
Evaluating oxidative stress in tumor cells. (A) Schematic of the LBL assembly of RGO–Au–
PTBO modified GCE used for detecting H2O2 efflux from cells stimulated with AA. (B) 
Amount of H2O2 released by PC12, RSC, L02, HepG2, and K562 cell lines stimulated by 4 
μM AA. The values are expressed as means ± SD of at least three independent 
measurements. Reprinted with permission from ref 152. Copyright 2013 Elsevier.
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Figure 22. 
Multiplexed fluorescence resonance energy transfer aptasensor. (A) Schematic illustration of 
the multiplexed upconversion fluorescence resonance energy transfer between aptamers-
UCNPs and GO for FB1 and OTA detection. (B) Upconversion fluorescence spectra of the 
multiplexed UCNPs-GO FRET aptasensor in the simultaneous presence of 0–100 ng mL−1 
FB1 and OTA. (C) A standard curve of the fluorescence intensity versus OTA concentration 
and (D) FB1 concentrations measured by this developed method. Reprinted with permission 
from ref 156c. Copyright 2012 American Chemical Society.
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Figure 23. 
FRET between QDs and GO to sense biomolecules. (A) Schematic representation of GO-
induced fluorescence quenching of MB-QDs and biosensing mechanism. (B) Fluorescence 
emission spectra of MB-QDs (50 nM) after incubation with (a) target (800 nM), (b) single-
base mismatch strand (800 nM), (c) three-base mismatch strand (800 nM), and (d) no target 
and then addition of GO (0.1 μg/mL) for 5 min. Inset: Fluorescence intensity ratio F0/F for 
four cases. Reprinted with permission from ref 156b. Copyright 2010 American Chemical 
Society.
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Figure 24. 
DNA-templated silver nanoclusters–GO hybrids for the detection of multiple nucleic acids. 
(A) Schematic representation of the preparation of silver nanoclusters on DNA scaffolds in 
aqueous solution. (B) Schematic illustration of the assay for label-free DNA detection using 
AgNCs–GO nanohybrid materials. (C) Fluorescence emission spectra of P1 (1 mM) upon 
addition of T1 with different concentrations: (a) control; (b) 1 nM; (c) 5 nM; (d) 10 nM; (e) 
50 nM; (f) 100 nM; (g) 300 nM; (h) 600 nM; (i) 800 nM; and (j) 1000 nM, which was then 
quenched with GO. Inset: A zoomed-in view of the data for low concentrations of target (a–
e). (D) Linear relationship between (F − F0)/F0 (relative fluorescence intensity, where F0 and 
F are the fluorescence intensities without and with the presence of target DNA, respectively) 
and the concentration of target DNA (1–1000 nM). Error bars were obtained from three 
parallel experiments. Reprinted with permission from ref 165. Copyright 2012 Royal 
Society of Chemistry.
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Figure 25. 
Graphene–AuNP-based SERS platform for multiplex DNA detection. The large-sized 
graphene films were grown by CVD on copper foils and then transferred onto SiO2/Si 
substrate. Graphene film was then decorated with AuNPs by immersing it into HAuCl4 
solution. The detection of target and multiplex (two targets) DNA by Au-G–SiO2/Si 
substrate-based SERS sensor. SERS spectra obtained in the absence of target DNA (black, 
C) and in the presence of 1 nM non target DNA (red, B) and complementary target DNA 
(blue, A). Reprinted with permission from ref 174. Copyright 2012 American Chemical 
Society.
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Figure 26. 
Graphene–AgNP sensor based on electrophoretic preconcentration and SERS. Schematic 
representation of a disposable Ag–graphene sensor for the detection of polar antibiotics in 
water. The magnification insets show the fabrication of Ag–graphene sensors and the 
electrophoretic preconcentration process of polar antibiotics. The distribution of antibiotics 
molecules is sketched for the case of a negatively charged analyte. At a given potential, most 
of the negatively charged antibiotics are concentrated onto the positively charged printed 
electrode, due to the generated electric field between the working electrode and the counter 
electrode. In SERS experiments, the laser comes vertically from the side view of the 
spectroelectrochemical cell and is focused on the Ag–graphene sensor. SPE = screen-printed 
electrodes. Reprinted with permission from ref 178. Copyright 2013 Elsevier.
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Figure 27. 
Intracellularly grown GO–AuNP hybrids for SERS. (A and B) TEM images of A549 cells 
containing GO/PVP/IGAuNs nanocomposites. (C, GO/PVP/IGAuNs; and D, IGAuNs) 
SERS spectra of A549 cells collected from the regions corresponding to the cytoplasm, 
nucleoplasm, and nucleolus. Reprinted with permission from ref 179. Copyright 2012 
American Chemical Society.
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Figure 28. 
In situ growth of β-FeOOH nanorods on GO for in vivo MRI and cancer therapy. (A and B) 
TEM images of β-FeOOH nanorods on GO. AFM images of (C) GO-COOH, (D) GO-PEG, 
and (E) GO-PEG-β-FeOOH. (F) T2-weighted MR images of GO-PEG-β-FeOOH. (G) Plot 
of 1/T2 versus Fe concentration in GO-PEG-β-FeOOH. The slope indicates the specific 
relaxivity (r2). (H) T2-weighted MR images of HeLa cells after 4 h incubation with different 
concentrations of GO-PEG-β-FeOOH. Reprinted with permission from ref 195. Copyright 
2013 Royal Society of Chemistry.
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Figure 29. 
GO–AuNP hybrid-based SERS probe for cancer cell imaging. (A) Scheme for the 
preparation of GO and Au nanoparticle decorated GO (Au/GO hybrids). Optical (B, D, F, H) 
and Raman (C, E, G, I) images of HeLa 229 cells. Cells were incubated in medium without 
GO (B and C), in medium with Au nanoparticles (D and E), in medium with GO (F and G), 
and Au/GO hybrids (H and I). Scale bars: 10 μm. Reprinted with permission from ref 197. 
Copyright 2012 Royal Society of Chemistry.
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Figure 30. 
GO–AIZS NP composites for cellular imaging. (A) Schematic illustration of the procedure 
for synthesizing fluorescent zinc-doped AgInS2 quantum dot decorated GO (AIZS–GO) 
nanocomposites. (B) The photoluminescence spectra of AIZS–GO nanocomposites 
suspended in water. (C) Confocal laser scanning microscope (CLSM) images (top row) and 
merged images (bottom row) of one typical NIH/3T3 cell tagged with yellow color emitting 
AIZS–GO–PEG nanocomposites at different cross sections (1 μm intervals). Scale bars: 10 
μm. Reprinted with permission from ref 204. Copyright 2013 Royal Society of Chemistry.
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Figure 31. 
Plasmonic nanoparticles coated with rGO for photothermal therapy. Schematic 
representation of (A) rGO coated Au nanoparticles (rGO–AuNS) and (B) rGO coated Au 
nanorods. HR-TEM image of (C) rGO–AuNS and (D) rGO–AuNR. (E and F) Solution 
temperature changes over time upon irradiation (3.0 W cm−2, 808 nm) of solutions of coated 
and uncoated nanoparticles and distilled water (DW). (G) Photothermal cell killing with 
rGO–AuNS and rGO–AuNR, measured by live/dead assay after 30 s, 2 min, and 5 min of 
irradiation (3.0 W cm−2, 808 nm). The dotted white line represents the boundary of the 
irradiated area. Reprinted with permission from ref 209. Copyright 2013 American 
Chemical Society.
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Figure 32. 
GO–AuNP composite for dual bioimaging and photothermal therapy. (A) Schematic 
illustration of GO-IONP-Au nanocomposite synthesis. (B) IR thermal images of tumor-
bearing mice injected with saline, GO-PEG, or GO-IONP-Au-PEG under laser irradiation 
(808 nm, 0.75 W/cm2). Reprinted with permission from ref 211. Copyright 2013 Elsevier.
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Figure 33. 
GO wrapped AuNPs for intracellular Raman imaging and drug delivery. (A) Illustrative 
mechanism of SERS-based bioimaging and anticancer drug delivery by using Au@NGO. 
(B) Confocal laser scanning microscopy (CLSM) images of HeLa cells treated with DOX-
loaded Au@ NGO (Au@NGO + DOX, 25 μg mL−1) for different times. (C) MTT 
cytotoxicity assay of HeLa cells after being treated with DOX-loaded Au@ NGO 
(Au@NGO + DOX) and free DOX. Reprinted with permission from ref 218. Copyright 
2013 Royal Society of Chemistry.
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Figure 34. 
Remote-controlled drug release from GO-capped mesoporous silica to cancer cells by 
photoinduced pH-jump activation. (A) Schematic illustration of DOX@MS-BA-GOF as a 
drug delivery system for remote light control of drug release. (B) TEM images of amine-
terminated mesoporous silica (b1), boronic acid-grafted MS (b2), and GO-capped MS-BA 
(b3). (C) Viability of HeLa cells after being incubated with different nanoparticles (MS-BA-
GOF, MSP-BA-GOF, and DOX@MSP-BA-GOF). Cytotoxicity of DOX@MSP-BA-GOF 
and DOX@MSP-BA-GO incubated with HeLa cells and L02 cells for 24 h. Reprinted with 
permission from ref 224. Copyright 2014 American Chemical Society.
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Figure 35. 
Multifunctional chitosan magnetic-graphene nanoparticles for tumor-targeted codelivery of 
drugs, genes, and MRI contrast agents. (A) Schematic showing the generation of DOX-
loaded chitosan functionalized magnetic graphene complexed with DNA plasmids encoding 
GFP (DOX-CMG-GFP-DNA) complexes. (B) GFP expression and DOX fluorescence in 
frozen sections from mice injected with DOX-CMG-GFP-DNA (30 μg of DOX and 25 μg of 
GFP-DNA), examined using a fluorescent microscope at 400× magnification. Expression 
was quantified and normalized to control background. Reprinted with permission from ref 
228. Copyright 2013 Royal Society of Chemistry.
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Figure 36. 
rGO/carbon/mesoporous silica nanocookies for NIR-triggered photochemothermal therapy. 
(A) Schematic illustration of chemo-photothermal therapy using reduced graphene oxide/
carbon/mesoporous silica nanocookies, under NIR light-control. (B) FE-SEM and (C) low 
magnification TEM images of nanocookies. Inset: High magnification images of a 
nanocookie. (D) Infrared thermal images of a MDA-MB-231 tumor-bearing nude mouse 
treated with PBS+NIR (control), CPT+NIR, nanocookie-CPT (no NIR), nanocookie+NIR, 
nanocookie-CPT+NIR treatment. Color bar on right shows temperature in °C. Pictures at 
day 4 after NIR irradiation (808 nm, 0.75 W cm−2, 5 min, 1 min interval for every min 
treatment) show the tumor turned into a scab at the site injected with nanocookie+NIR and 
nanocookie-CPT+NIR. White circles represent tumor sites. (E) Changes in body weight and 
tumor volumes following treatment. Reprinted with permission from ref 238. Copyright 
2014 Wiley.
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Figure 37. 
Graphene–nanoparticle hybrids to guide neural stem cell differentiation and axonal 
alignment. (A) Schematic diagram depicting the varying conditions and influence of 
nanoparticle (NP) monolayers coated with graphene oxide (GO) on the alignment of axons 
extending from human NSCs, and the differentiation into neurons. The differentiated human 
NSCs (orange) and the NPs-coated with GO (blue) in the SEM image show enhanced 
neuronal differentiation and axonal alignment. (B) Differentiated human NSCs, 
immunostained with TuJ1 (red), show no alignment of axons on glass (control) and SiNP 
films, whereas the axons are significantly aligned on GO and SiNP-GO films. Scale bar: 10 
um. Compass plots show a large variation in the angle of orientation of axons on glass 
(±42°) and SiNPs (±46.11°) and minimal variation on GO (±17.8°) and SiNP-GO (±9.16°). 
Plots also show that axons extending on SiNP and SiNP-GO are longer than those extending 
on glass and GO. Reprinted with permission from ref 244. Copyright 2013 Wiley.
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Figure 38. 
Biocompatibility of graphene materials. Effects of GO on human fibroblast cells. (A) The 
survival rate at different concentrations of GO and at different periods of exposure. (B) TEM 
picture showing the location of GO inside human fibroblast cells as indicated by the black 
arrows. Reprinted with permission from ref 248. Copyright 2011 Springer. (C) Differential 
interference contrast image showing the accumulation of pristine graphene on the plasma 
membrane of Vero cells. (D) Fluorescence confocal microscopy of cytoskeletal F-actin 
arrangement of cells treated with pristine graphene. Reprinted with permission from ref 249. 
Copyright 2011 Royal Society of Chemistry.
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Figure 39. 
Biocompatibility of graphene–nanoparticle hybid materials. (A) Biodistribution of 125I-
RGO-IONP-PEG in 4T1 tumor-bearing mice. High uptake was observed in the RES (e.g., 
liver and spleen) as well as in the tumor. (B) Fluorescence imaging using Cy5 labeled RGO-
IONP-PEG showing biodistribution. Reprinted with permission from ref 207. Copyright 
2012 Wiley. (C–F) Cellular uptake of FA-QD-S-rGO in MCF-7 cells (C) and HeLa cells (E) 
showing QD fluorescence (red-orange) in many regions, and that of FA-QD-S-rGO in 
MCF-7 cells (D) and HeLa cells (F), showing QDs mostly at the cell surface. (G) Confocal 
images of multiple cross sections (bottom and right), exhibiting various locations of the QD-
rGOs within the MCF-7 cells. Reprinted with permission from ref 212. Copyright 2012 
Wiley.
Yin et al. Page 107
Chem Rev. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 40. 
Hysteresis-based enzyme detection using a graphene–nanoparticle hybrid sensor. (A) 
Graphene–nanoparticle hybrid devices for enzyme sensing. (B) Chemical structure of the 
functional polypeptide linker molecule. (C) Fabrication process of the hybrid biosensor. 
Fabrication of the graphene channel between the Au electrodes (i). Functionalization of the 
graphene surface with hydrophilic molecules (ii). Assembly of the functional peptide linker 
molecules and AuNPs on the polypeptide layer (iii). (D) Change in VDirac under various 
periods of exposure to a 1 μM solution of carboxypeptidase B in PBS, 1 mM PBS solution, 
and 1 mM solution of BSA in PBS. Reprinted with permission from ref 110. Copyright 2012 
Wiley.
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Table 1
Summary of the Different Methods Used To Prepare Graphene–Nanoparticle Composites
method typical NPs key characteristics key refs
reduction metal NPs, 
especially noble 
metals
(1) one-pot synthesis; (2) highly efficient and easy to perform; (3) can be difficult to 
control the size and morphology of the NPs; however, can be addressed by using 
microwave-facilitated reduction
30, 39–55
hydrothermal metal oxide NPs, 
QDs
(1) can create NPs with high crystallinity and narrow size distribution; (2) high 
temperature and long reaction times can partially or completely reduce GO on its own
56–76
electrochemical metal NPs, 
especially noble 
metals
(1) simple, fast, and green technique; (2) low cost, easy to miniaturize and automate, and 
is highly stable and reproducible; (3) pulse current can be adjusted to control density, 
size, and morphology of NPs; also allows for simultaneous reduction of GO
78–84
ex situ inorganic NPs, 
especially noble 
metals
(1) NPs are synthesized in advanced; this allows for precise control of the size, shape, 
and density of the NPs that are used to form hybrids; (2) ex situ methods include 
covalent or noncovalent interactions such as van der Waals interactions, hydrogen 
bonding, π–π stacking, or electrostatic interactions
86–103
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Table 2
Summary of the Different Detection Mechanisms Discussed
type common NPs LOD advantages key refs
FET Au, Pt, SiO2 aM–pM (1) enhanced surface area for detection; (2) can preserve the 
electrical properties of graphene by conjugating the probe on the 
nanoparticle
124, 127, 128, 130
electrochemical Au, Pt, Cu pM–μM (1) immobilization of biomolecules; (2) catalyze electrochemical 
reactions; (3) act as a reactant
137, 140, 143–146, 148–152
FRET QD, UCNP, Au, Ag pM–nM (1) GO is superquenching, which can result in double-quenching 
(e.g., with Au or Ag)
156, 162, 163, 165
SERS Au nM (1) dual enhancement of Raman signals via chemical and 
electromagnetic enhancement
174–179, 181
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